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Pluripotent stem cells in the domestic cat model represent a huge potential for disease 
modeling, drug screening and regenerative medical treatments for feline species as 
well as for humans. However, current knowledge on deriving and maintaining stem 
cells has been obtained primarily from studies in mouse, rat, and human. Difficulties 
in attaining similar results in cats indicate the necessity to better understand 
pluripotency in this species. The hypothesis was that inadequate cytokine 
supplementation results in pluripotency loss along with declining transcription factors 
 
 
expression. The main goal of this project was to assess the effects of selected growth 
factors and inhibitors, in maintaining pluripotency in embryonic cells, and to attain 
pluripotency from fibroblasts by controlling expression of exogenous transcription 
factors. In the first study, conventional cytokine cocktails, leukemia inhibitory factor 
coupling with glycogen synthase inhibitor 3, and mitogen-activated protein kinase 
inhibitor (LIF and 2i) could partially maintain pluripotency regulatory circuitry in the 
cat. In this condition, embryonic cells reached a state that was not fully defined (neither 
naive nor primed). Overall, cell characterizations revealed a trend of pluripotency loss 
over time. In the second study, pluripotency was attained by forced expression of 
inducible exogenous transcription factors (NANOG, POU5F1, CMYC, and SOX2) 
and cultured in medium supplemented with the same cytokine combination identified 
in the first study. Notably, unlike previous reports in the cat, colonies with partial 
pluripotent features could be maintained after the transgenes were silenced. In addition 
to the protein and transcript markers for pluripotency, lineage marker dynamics were 
examined in pluripotent cells and embryoid bodies. The outcome suggested the cells 
generated with LIF and 2i had developed beyond the undifferentiated stage of ICM in 
expanded blastocyst. Collective results not only challenged the efficacy of the 
cytokines combinations LIF and 2i in maintaining feline pluripotency, but also suggest 
direction of research towards the species-specific signaling requirement in embryonic 
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Chapter 1 Introduction 
1.1 Biology significance of pluripotent stem cells in the domestic cat (Felis Catus) 
model 
The value of generating pluripotent cells in domestic cats is comparable to that of 
such versatile cells in mouse and human, for the reasons below, 
1) The feline family included many endangered species 
(http//www.iucnredlist.org).  The domestic cat has been used as a model for 
developing assisted reproductive technologies for preserving endangered wild cats 
(Gomez et al., 2000; Fernandez et al., 2015). Because domestic cats have genetic and 
anatomic similarity to the other members in Felidae and have a highly conserved 
genome as compared to primate family (Johanson et al., 2006), they can also serve as 
a model for studying stem cells. By establishing pluripotent cells in vitro, the clinical 
use of stem cells for endangered species in regenerative medical treatment and drug 
screening becomes possible. In all, the lessons we will learn from establishing 
pluripotent cells in domestic cats is of great advantage for expanding such study to 
other cats. 
2) Humans and cats share more than 250 diseases, which afflict in similar ways 
(Hedges et al., 2006 and Meredith et al. 2006). Therefore, even though mice have less 
evolutionary distance, the cat is a better model in stem cell engineering for some 
diseases (e.g., FIV and HIV), which share more similarity to the human disease (Lee 
et al., 2017). In addition, biomedical applications could be tested extensively (e.g., 
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transgenic cell or organs) prior to consideration for translation to human medicine. 
3) Domestic cats are obligate carnivores and considered the representative for 
Felidae. This family, which last shared a common ancestor with humans around 92 
million years ago, are evolutionary further from human than rodents (Hedges et al., 
2006 and Meredith et al. 2006). Studies for acquisition of pluripotent stem cells in 
these animals not only broaden the view of regulating pluripotency, but also deepen 
the understanding of the how these mechanisms adapt to different evolution paths.  
The success of generating pluripotent stem cells for the feline family relies on the 
knowledge acquired from studies in rodents and humans, as described more fully 
below.  
Pluripotent stem cells are cells that have two features, 1) potential to produce all 
cell types (>200) in a body and 2) unlimited self-renewal (Bradley A. et al. 1984; 
Takahashi and Yamanaka, 2006). Based on the origin, there are two major types of 
pluripotent cells in vitro, embryonic stem cell (ESC) from embryos and induced 
pluripotent stem cell (iPSC) from somatic cells (Nakagawa et al., 2008). The first 
pluripotent stem cells were identified in mouse testicular teratocarcinoma. It was 
recognized that carcinoma cells could give rise to cells in various types after 
transplantation into endodermal, mesodermal and ectodermal lineages (Stevens 1960 
and 1962). Because these cells shared features with inner cell mass (ICM), which could 
be used to generate teratomas, ESCs were then directly obtained from mouse pre-
implantation embryos (Evans and Kaufman, 1981; Martin, 1981). By now, mouse 
ESCs are still the best-understood type of pluripotent cells. With the knowledge gained 
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from ESCs, another equivalent type of pluripotent stem cell in this species was 
generated in 2006 (Takahashi and Yamanaka, 2006). These cells were reprogrammed 
somatic cells that have been reversed to the undifferentiated state (Takahashi and 
Yamanaka, 2006), and they have the same potential to contribute to all cell types as 
ESCs.  
ESCs are derived from an embryo and are not genetically matched to an 
individual, so they are unlikely to be used in customized medical treatment. They are 
studied to advance the knowledge of how stem cells sustain, differentiate, and react to 
defined environments. IPSCs, on the other hand, are reprogrammed from somatic cells, 
and possess great therapeutic values (Nakagama et al., 2008; Takahashi et al., 2007). 
IPSCs are genetically matched to their donor, thus they inherit the same genome and 
partial DNA methylation pattern, which make them useful for drug screening in treating 
genetic disease (Beevers et al., 2013). This feature minimizes tissue rejection response 
of the donor hence leads to successful cell and tissue transplantation (Takebi et al., 
2013). Gene-edited iPSCs can give rise to mutant or genetic modified offspring, which 
help scientists understand how different phenotypes emerge from the similar 
genotypes with minor variation (Lin et al., 2018). These findings have expanded the 
view of in vitro cell modeling of disease. 
In addition to what has been learned from mouse ESCs and iPSCs, the robust 
translation of mechanism in maintaining pluripotency and directing differentiation 
between these two cell types has encouraged a series of similar studies in other species 
(Buehr et al., 2008; Carey et al., 2009; Debowski et al., 2015; Gomez et al., 2010). 
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Looking into mammalian embryogenesis, the early epiblast, the origin of ESC, is a 
conserved stage during development in vivo (Forgács and Newman, 2005). Extensive 
studies in mouse ESC and iPSC have proven that those pluripotent cells produced in 
vitro are competent when inserted into a recipient embryo to produce a chimera. They 
contributed to form organs from all three germ layers, and the offspring of chimeric 
mice inherited genetic markers from those ESC and iPSC cell lines (Cai et al., 2015; 
Nakagawa et al., 2008; Takahashi et al., 2007). With the understanding that the core 
networks regulating pluripotency in ESC and iPSC are shared, such machinery is 
thought to be present in other mammals also. Yet, the same level of success cannot be 
achieved in most other species tested (Madeja et al., 2015; Okita et al., 2016; Verma 
et al., 2012).  
Rat and human studies demonstrated that additional inhibitors and manipulation 
are required to generate ESC (Buehr et al., 2008; Ware et al., 2014), while rabbit and 
bovine studies have not produced the same type of pluripotent cells (Madeja et al., 
2015 and Osteil et al., 2016). Neither ESC nor iPSC has been established in domestic 
cats, although several studies report partial success, in which those pluripotent-like 
cells either differentiated in a few passages or relied on exogenous gene expressions 
(Gomez et al., 2010; Yu et al., 2008; Verma et al., 2012). Further efforts to understand 
how pluripotency is regulated regarding the pluripotency-related transcription factors 
(TFs) and the species disparities in this regulation are needed, before successful 
derivation of ESC and iPSC can be achieved in felids and other non-rodent species. 
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1.2 Literature review 
1.2.1 Pluripotency regulatory circuitry 
Pluripotency in embryonic and induced stem cells, 
In the mouse model, ESCs are derived from ICM in expanded blastocysts on 
Day 3.5 (Czechanski et al., 2014). In cat, ESC-like cells were generated from ICM in 
blastocysts with the similar morphology, on a later time – Day 7-9 (Fig. 1.1). The 
ICMs in different species share the critical TFs, Nanog homeobox (NANOG), POU 
domain, class 5, transcription factor 1 (POU5F1 aka. octamer-binding transcription 
factor 4, OCT4), and Sex determining region Y box 2 (SOX2). These TFs are 
responsible for maintaining pluripotency in ICM and epiblast (Niakan KK et al. 
2013), as well as iPSCs (Takahashi and Yamanaka, 2006). There are specific 
signaling pathways that regulate these TFs (Fig. 1.2). Each factor has their own 
functions in gene regulation and they coordinate with each other in a balanced 





           Zygote     2-cell     8-cell     Morula      Blastocysts 
Figure 1.1 Timeline of key stages of early embryogenesis in cat, mouse and human. 
Pink cells represent totipotent blastomeres from zygote to 8-cell stage, red (ICM) and 






Figure 1.2 A) Pluripotency regulation circuitry between TFs; B) Activation of four 
major pathways and inhibition of WNT pathway maintain ESC and iPSC pluripotency. 
In Naïve state, LIF binds to its receptor and signals through phosphorylation of STAT. 
In primed state, FGF2 binds to its receptor and activates MEK/ERK. 
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NANOG is the ground state marker and regulator of pluripotent stem cells (Cai 
et al., 2015; Yates et al., 2005). In ICM or pluripotent stem cells in vitro, over 50% 
of promoters that are actively regulated are bound by NANOG. Ninety percent of 
promoters bound by POU5F1 and SOX2 also have NANOG bound. Likewise, 50% 
of POU5F1 target genes also showed co-occupation by SOX2. These indicate genes 
are co-regulated by all three TFs. Moreover POU5F1, SOX2 and NANOG bind to 
their own promoters in a self-regulatory positive/negative feedback loop, and 
POU5F1-SOX2 hetero-dimer and NANOG also bind to each other's promoters 
(Rodda et al. 2005). NANOG, OCT4/POU5F1 and SOX2 co-bind to each other's 
enhances to maintain ESC properties, and they also repress each other on the 
promoter regions when excess expression is not necessary (Cai et al., 2015) (Fig. 
1.2A). These three core transcription factors target over 300 hallmark genes of ESC, 
which are either repressed or activated (Nakagawa et al., 2008; Wang et al., 2012). 
This basic understanding may apply to various species including felids.   
Four pathways [Leukemia inhibitory factor (LIF)/ Signal transducer and activator 
of transcription 3 (STAT3), Bone morphogenetic protein (BMP), Activin/Nodal, 
Mitogen-activated protein kinase (MEK)/ Extracellular signal-regulated kinases 
(ERK)] have been reported and validated in mouse, rat, rabbit, and human, as being 
involved in maintaining ground state pluripotency (Duggal et al., 2015; Gao et al., 
2015; Hayashi et al., 2011; Hou et al., 2013) (Fig 2). In addition to these four pathways, 
the Wingless-type mouse mammary tumor virus integration site family member (WNT) 
pathway also contributes to supporting pluripotency in stem cells (Madeja et al., 2015; 
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Munoz-Descalzo et al., 2015; Pieters and Van Roy, 2014). These pathways activate 
the core transcriptional regulatory circuitry of NANOG, POU5F1 and SOX2 for 
maintaining pluripotency and self-renewal in different states, whereas FGF2 pathway 
takes over the control during development (Evans and Maufman, 1981; Nicholas and 
Smith 2009; Thomson et al., 1998). 
However, differences were observed between mouse and human ESC, which 
resulted in the distinction of naive and primed states of ESCs. Naïve ESCs like mouse 
ESC should have unlimited self-renewal and clonal capacity (i.e., can be propagated 
as single cells). They also should exhibit pre-implantation epiblast identity and potency, 
which is identified by the presence of two active X chromosomes in female cells 
(Bradley A. et al. 1984), along with the ability to incorporate into the epiblast and re-
enter development to produce various somatic and germ cells when forming chimera 
embryos. The human ESC is derived from in vitro cultured embryos donated to 
assisted reproduction clinics (Thomson et al., 1998). Initial attempts followed the 
protocols in mouse. Yet early human ESCs are more like post-implantation epiblast 
and do not survive passage as single cells (no clonal expansion). Thus, the human 
ESCs are similar to cells at a more developed stage compared to mouse ESC and 
exhibit what is known as primed pluripotency (Duggal et al., 2015; Thomson et al., 
1998). The major difference is shown in Table 1 (Nicholas and Smith 2009; Rossello 





       
Table 1.1 Property of Naive and primed state of ESCs 
Characteristics Naïve Primed 
Origin Early epiblast 
Egg cylinder/embryonic 
disc/late epiblast 
In vitro phenotype Rodent ESC 
Rodent epiblast stem cells 
(EpiSCs) and primate 
ESCs 
Pluripotency markers 
OCT4, NANOG, SOX2, 
KLF, KLF4 
OCT4, NANG, SOX2 
Naive markers REX1, NR0B1, FGF4 None 
Specification markers None FGF5, T 
Response to LIF/STAT3 Self-renewal None 
Response to MEK/ERK Differentiation Self-renewal 
Clonogenicity High Low 









Besides the TFs shown in Table 1.1, another TF is important for stabilizing the 
cell state. Myelocytomatosis oncogene (MYC) gene (known for cell proliferation 
control) is conditionally needed to maintain naive ESC (Scognamiglio et al., 2016). 
Primed (epiblast) stem cells (EpiSCs) can convert to naive state when expression of 
Kruppel-like factor 4 (KLF4) or MYC is forced in EpiSCs with LIF supplementation. 
LIF supplemented with bovine fetal serum (FBS) plus MEK inhibitor and glycogen 
synthase kinase beta 3 (GSKβ3) inhibitor can be sufficient to induce such conversion 
(Rossello et al., 2016). Combined knowledge from mouse, rat, and human ESCs 
studies may provide guidance when developing the protocol for cat ESC.   
1.2.2 Approaches to achieve pluripotency balance 
Induction of pluripotency 
Pluripotency in ESC is built on the natural presence of the SOX2, POU5F1and 
NANOG (Evans and Kaufman, 1981). For embryo development and cell 
differentiation, varying levels of these TFs are needed (Rodda et al., 2005). In somatic 
cells, all the three genes are down-regulated (Le et al., 2014). Thus, the strategy for 
inducing pluripotency in somatic cells is to reverse differentiation by over-expressing 
TFs responsible for maintaining pluripotency (Tanabe et al., 2014), and selection of 
cells reprogrammed into a pluripotent state (Takahashi and Yamanaka, 2006). A 
summary of recent strategies for transduction of transcription factors used for iPSC 
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Small chemical 
molecules 






dog, rabbit, rat, 
sheep, monkey 
30% Le et al., 2014 
12 
 
Every method is based on the foundation of forcing expression of these four TFs- 
POU5F1/OCT4, SOX2, KLF4 and c-MYC. Regardless the vector/methodology used, 
a complete reprogramming requires at least 16 days of forced expression of the 
pluripotent transcription factors and a defined culturing environment for maintenance. 
In the study using the piggyBac system (Tonge et al., 2014), a new type of pluripotent 
cell - F(uzzy)-class cells (clones having a fuzzy border), expressed endogenous 
NANOG and POU5F1/OCT4, but not most of the other ESC-associated genes, and 
they were dependent on the continuous expression of high levels of exogenous 
reprogramming factor. Only after the silencing of ectopic TFs, were the cells able to 
obtain the endogenous pluripotent balance and acquire the ability to contribute to 
chimeras (Wang et al., 2012; Zunder et al., 2015). This finding proved the importance 
of both establishing the endogenous pluripotency circuit while silencing the exogenous 
transgenes to complete reprogramming.  
1.2.3 Status of generating pluripotent cells in the domestic cat 
Like in other species, it should be possible to produce ESC or iPSC in domestic 
cats. However, attempts of maintaining/inducing stem cell have not been satisfactory 
(Gomez et al., 2010; Yu et al., 2008; Verma et al., 2012). Yu et al. (Yu et a., 2008) 
used in vivo-derived blastocysts to ensure the quality of embryos. ICM was isolated 
and cultured on cat embryonic fibroblast (CEF) in medium containing 1000U/ml 
recombinant mouse LIF. Gomez et al. (Gomez et al., 2010) used in vitro-cultured 
blastocysts to serve the same purpose but cultured the ICM with 5 ng/ml human 
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recombinant basic fibroblast growth factor (FGF2). Regardless of supplementation 
with different growth factors, the putative colonies would differentiate spontaneously. 
The colonies in late-passage (9-12 passages) lost stem-like features and failed to 
proliferate. While there seems to be no difficulty in isolating good quality ICM from 
cat blastocysts produced either in vivo or in vitro, there is an issue of establishing 
outgrowth cultures and subsequent propagation. The protocols proven efficient in 
mouse and human ESC, therefore, do not guarantee the success for cat ESC. The 
reason might be a varying reliance on each pathway in different species when 
propagating pluripotent cells from early-stage embryos. In mouse ESC, the 
LIF/STAT3 signaling pathway plays a major role in maintaining pluripotency while 
MEK/ERK is the critical pathway for human ESC (Angeles et al., 2015; Nicholas and 
Smith 2009). A recent study found that human ESC couldn't contribute to chimera 
formation, unlike mouse ESC (Duggal et al., 2015). Characterization of human ESC 
indicated that it is equivalent to late epiblast cells (post implantation stage). Human 
ESC can be transformed to a state like mouse ESC by activating LIF/STAT3 pathway, 
but human ESC will differentiate if support from MEK/ERK pathway is removed 
(Nicholas and Smith 2009; Rossello et al., 2016). In cats, neither supplementation of 
LIF nor Fibroblast growth factor 2 (FGF2 aka bFGF) support the maintenance of 
pluripotency in cells derived from inner cell mass (ICM) (Gomez et al., 2010; Yu et 
al., 2008). Furthermore, while forced expression of transcription factors in initiated 
reprogramming in fibroblasts from a snow leopard; the characterization of the cells 
showed incomplete reprogramming that lacked activation of endogenous genes 
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(Verma et al., 2012). In this study, human genes (OCT4, SOX2, KLF4, cMYC and 
NANOG) were integrated using Moloney-based retroviral vector into snow leopard 
genome.  Colonies were obtained and split after reprogramming, however, KLF4 and 
cMYC remained active throughout 36 passages, and thus it was an incomplete 
reprogramming. These results indicated that using methods for mouse and human cells 
was not sufficient to reprogram cat somatic cells into pluripotent cells.  In all, these 
studies raise some questions concerning pluripotency in cats. Which pathways are 
necessary to propagate embryonic pluripotent cells? Which genes are required in 
reprogramming somatic cells? The answers are necessary for achieving our goal of 
maintenance of pluripotent cells in domestic cats. 
1.3 Project overview 
While transgene-free reprogrammed iPSC would be the ultimate objective, 
allowing for broader utilization of iPSC in applications directed towards regenerative 
medicine and species preservation, the overall goal in this study was to produce ESC 
or iPSC in domestic cats. The hypothesis was that inadequate cytokine 
supplementation results in pluripotency loss. To determine whether cytokines can 
stimulate pathways that regulate pluripotency in cells derived from cat ICM, the levels 
of known TFs and their upstream pathways were investigated under varying cytokine 
supplementation. In the approach of transforming somatic cells to iPSC, human 
transcription factors POU5F1, SOX2, KLF4, cMYC and NANOG were used to force 
reprogramming and the resulting cells assessed for pluripotency characteristics after 
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culture with the cytokines growth factors identified in the ICM studies. Cells that were 
generated from these two experiments, could be widely expanded and possessed some 
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Chapter 2 Combinations of growth factors regulating LIF/STAT3, WNT and 
FGF2 pathways pluripotency-related proteins in cat embryonic cells 
Portions of this chapter have been submitted to Stem Cells and Development. 
2.1 Abstract 
Propagation of pluripotent cells from early-stage embryos in mouse and human 
highly depend on LIF/STAT3 and FGF2/MEK/ERK signaling pathways. However, 
mechanisms for maintaining pluripotency in embryonic stem cells (ESC) using various 
combinations of growth factors (targeting LIF or FGF2 pathways) and inhibitors 
(targeting WNT/GSK3 or FGF2 pathways) still have to be deciphered in other models, 
including the domestic cat. Our objective was to understand how cytokines influence 
pluripotency in the cat inner cell mass (ICM) outgrowths. Cat ICM were isolated from 
in vitro produced embryos and outgrowths were cultured for up to 6 days with single 
or combined cytokines. Cell proliferation was enhanced with almost all single growth 
factors and cytokine combinations. Based on gene expression and presence of 
NANOG, POU5F1 and SOX2 as cell state markers, single growth factors could not 
maintain similar levels in outgrowth as in the original ICM, which is different from 
the mouse and human. In our conditions, cytokine combinations involving LIF, GSK3 
inhibitor and MEK inhibitor resulted in the most robust expression levels. However, 
further characterization of embryonic cells derived from ICM indicated that the 
pluripotent state was not fully preserved. Specifically, low levels of LIF-receptor and 
STAT3 transcripts in ICM demonstrated that the insufficient response to LIF was due 
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to signaling variation in regulatory mechanisms of early embryonic cells. The absence 
of BMP2- receptor and SMAD4 expression also suggested that cat specific signaling 
pathway was needed to ensure pluripotency balance. Collective results reveal more 
options to improve the production of ESC in that fundamental animal model. 
2.2 Introduction 
Pluripotent stem cells have inherent capacity to differentiate into any cell type 
and to self-renew unlimitedly (Bradley et al., 1984; Takahashi and Yamanaka, 2006). 
The embryonic stem cell (ESC) is a major pluripotent cell type that can be produced 
and maintained in vitro (Martin, 1981; Sato et al., 2004) including for biomedical 
research, drug testing, genetic and congenital disease modeling, and regenerative 
medicine. Most ESC lines and studies have focused, so far, on common laboratory 
rodents (Martin, 1981; Czechanski et al., 2014). However, our research team has 
demonstrated the value of a larger-sized model, the domestic cat, for understanding a 
wide array of reproductive mechanisms analogous to the human (Comizzoli et al., 
2018). Moreover, the cat and human share more than 250 diseases (e.g., Feline 
Immunodeficiency Virus and human Acquired Immune Deficient Syndrome) (Lee et 
al., 2017). Other groups also have explored the development of domestic cat assisted 
reproduction technology that could have application to other felid species (Gomez et 
al., 2000; Fernandez-Gonzalez et al., 2015), many of which are classified as 
vulnerable to extinction (The International Union for the Conservation of Nature Red 
List http,//www.iucnredlist.org). The availability of cat ESC lines will greatly expand 
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such potential,  possible uses include drug safety screening on pluripotent cells and 
their derivatives after differentiation, and also in vitro tissue generation for cell-based 
therapies (Stem Cell Basics VII. stemcells.nih.gov). 
In earlier investigations, methods developed to establish ESCs in mouse and 
human did not lead to stabilized, pluripotent stem cells in the cat (Gomez et al., 
2010; Yu et al., 2008). This was likely due to insufficient prevention for 
differentiation in the culture system. From studies in the mouse model, we know how 
to maintain ESCs in vitro and how these cells differentiate and contribute to organ 
formation in chimeric embryos (Tesar, 2005). In addition, the core network of 
pluripotency in mouse (Tesar, 2005; Tesar et al., 2007), rat (Li et al., 2008) and 
human (Tesar et al., 2007; Wang et al., 2012) ESCs is a regulatory circuitry 
involving Nanog homeobox (NANOG), POU domain, class 5, transcription factor 1 
(POU5F1 aka OCT4) and Sex determining region Y box 2 (SOX2). Furthermore, 
four conserved pathways (Leukemia inhibitory factor [LIF]/ signal transducer and 
activator of transcription 3 [STAT3]), bone morphogenetic protein (BMP), 
activin/nodal, mitogen-activated protein kinase [MEK)/ extracellular signal-regulated 
kinases [ERK]) are involved in maintaining ground state pluripotency by regulating 
the NANOG, POU5F1 and SOX2 expressions (Chen et al., 2015; Duggal et al., 
2015; Eiselleova et al., 2009). We suspect that those same general mechanisms apply 
to the maintenance of pluripotency in the domestic cat. However, there are specific 
differences in embryonic peri-implantation development process in felids (Knospe, 
2002). For instance, blastocyst formation occurs about 8 days after conception, and it 
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will develop further to neurulation stage before implantation. This is quite different 
from what has been observed in mouse and human (Hogan et al., 1994). Therefore, 
we hypothesize that there also are species-specific variations for signaling pathway 
synergy in different mammalian models. To better elucidate the underlying 
mechanism in pluripotency, evaluation of cytokine effects targeting different 
pathways in cat embryos can be very informative. The objective of our study was to 
understand how the growth factors LIF and FGF2, GSK3 inhibitor and MEK 
inhibitor (known to be efficient for mouse and human ESC maintenance (Sato et al., 
2004; Pieters et al., 2014)) affect the pluripotency circuitry in cat embryonic cells. 
This could lead to the development of proper culture systems and applications for cat 
ESC. 
2.3 Materials and Methods 
In vitro maturation and fertilization of oocytes followed by embryo culture 
Approval from an Institutional Animal Care and Use Committee was not 
required as domestic cat ovaries and testes were obtained from local veterinarians 
following routine owner requested ovariohysterectomies or orchiectomies. These are 
exempt studies under Title 9, Code of Federal Regulations, Subchapter A- Animal 
Welfare, Part 1 to 3. Mature cat ovaries and testes were collected from local 
veterinary clinics, transported and processed within 6 hours of excision (Godard et 
al., 2009). Grade 1 immature oocytes were recovered from ovarian tissue and 
matured for 24 hours (Godard et al., 2009) (38.5°C, 6% CO2) in 50 µl drops of 
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human Quinn’s Advantage Blastocyst Medium (Origi) supplemented with bovine 
FSH and LH (Sigma) at 1 µg/ml. Spermatozoa were collected from excised cat 
epididymis in Ham's F10 medium (Irvine Scientific) (Hribal et al., 2012). After 
centrifugation (350 g x 8 minutes), spermatozoa were allowed a swim-up for 30 
minutes (38.5°C, 6% CO2.) and oocytes inseminated by co-incubation with motile 
spermatozoa (1 million/ml) for 24 hours. Resulting embryos with at least two 
blastomeres (48 hours post insemination) were cultured under the same conditions in 
Quinn’s Advantage Blastocyst Medium until 9 days after fertilization (Nestle et al., 
2012). Under our experimental conditions, percentage of cleaved embryos after in 
vitro maturation/fertilization was 46 ± 24.5% (mean ± SD), and the proportion of 
expanded blastocysts relative to total number of 2-cell stage embryos was 15 ± 
13.1%. Expanded blastocysts were selected for RNA extraction (n = 10), 
immunofluorescence (n = 5) and outgrowth culturing (n = 3-5) per treatment group. 
A total of 212 expanded blastocysts from 150 in vitro cultures were used during the 
entire study.  
Cat blastocyst outgrowth culture 
The zona pellucida of each blastocyst was removed in 1% Protease (Sigma) 
(Moor and Cragle, 1971) whole embryo was cultured on mouse mitotically 
inactivated embryonic fibroblasts (mEF) grown on 0.1% gelatin-coated (Sigma) in 4 
or 8-well chamber glass slides (Millipore) for 6 days. Blastocysts outgrown for 
further propagation were cultured in 96-well tissue culture plates (Olympus) until 
ICM expansion (considered for this investigation to be a two-fold increase in ICM 
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(Czechanski et al., 2014; Gomez et al., 2010). The medium was composed of 43% 
Knock-out Dulbecco's Modified Eagle's Medium, 43% Neural Basal Medium, 5% 
Knock-out Serum Replacement, 2% B27 Supplements and 1% N2 Supplements (Life 
Technologies). In Study I, nine single growth factor treatments human LIF 
(Kingfisher Biotech (at 1, 10 or 100 ng/ml; feline LIF (Kingfisher Biotech) at 1, 10 
or 100 ng/ml; FGF2 (Peprotech) at 5, 10 or 20 ng/ml), were assigned to each group 
(n = 4-5 blastocysts/group) from the blastocysts seeding day (Day 0). The 
concentrations were based on previous studies for different species, FGF2-human 
(Eiselleova et al., 2009); LIF-mouse (Czechanski et al., 2014). All blastocyst 
outgrowths were fixed and stained (as described below). The influence of cytokines 
supplementation in sustaining pluripotent protein markers were classified as follows, 
1) ‘excellent’ (maintaining protein concentration similar as in ICM on Day 0 and 
higher than control on Day 6); 2) ‘good’ (maintaining protein concentration lower 
than Day 0, but higher than control on Day 6); or 3) ‘poor’ (maintaining protein 
concentration lower than control on Day 0 and Day 6). In Study II, cat blastocyst 
outgrowths were cultured in groups (3-4 blastocysts/group) with growth factors in 
combinations comprised of cytokines having ‘good’ or ‘excellent’ effects on at least 
two protein markers in Study I, GSK3 inhibitor (Sato et al., 2004) and MEK inhibitor 
(Chen et al., 2015) were added in the treatment combination to enhance proliferation 
and prevent differentiation (Wang et al., 2012). The combinations tested were 





Assessment of protein expression in cat blastocyst outgrowths by 
immunofluorescence 
Day 7 to 9 blastocysts and blastocyst outgrowths cultured on glass slides for 6 
days were fixed (Nestle et al., 2012) by incubating in 4% paraformaldehyde (PFA) in 
PBS at room temperature (10 minutes) and then rinsing twice with DPBS (Sigma). 
Fixed cells were permeabilized by incubating with 0.2% Triton X-100 and 0.1% 
Tween 20 in PBS at room temperature (10 minutes), then rinsing twice in TBS with 
0.05% Tween 20. Outgrowths were rinsed in PBS once followed by blocking with 
Maxblock Blocking Medium (Active Motif) at 4°C overnight. Cells were incubated 
with the primary antibodies (anti-human NANOG [500-P236; Peprotech), anti-
human POU5F1 [MAB4401; Millipore) and anti-human SOX2 [SC1002; Millipore) 
at 1.5 µg/ml) in Maxbind Staining Medium (Active Motif) overnight (4°C) with 
gentle rocking. Cells then were washed three times (5 minutes each) with Maxwash 
Washing Medium (Active Motif). Cells were then incubated with the secondary 
antibodies (Alexa Fluor 488 goat anti-rabbit IgG [H+L), Alexa Fluor 647 goat anti-
mouse IgG1, Alexa Fluor 594 goat anti-mouse IgG2a (Thermo Fisher Scientific) at 1 
µg/ml) in Maxbind Staining Medium (room temperature, 1 hour, in the dark). Then 
cells were washed four times (5 minutes each) with Maxwash Washing Medium for 
imaging. Hoechst 33342(Invitrogen) was added during the third wash at 1 µg/ml to 
stain nuclei. Imaging was done using a Leica DMI 6000 inverted fluorescent 
microscope. Fluorescence intensities were analyzed using ImageJ for semi-
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quantification of proteins (NANOG, POU5F1 and SOX2). Intensities of each stained 
proteins were normalized to the average intensity in ICMs in Day 7 to 9 blastocysts 













Cat embryonic cell propagation 
Based on the protein intensities measured in Study II, one cytokine combination 
was selected for further embryonic cell propagation for assessing cytokine effect in 
synergy for long-term culture (Study III). The percentage of blastocysts (n=41) 
adhering to mEF feeders and expanding to at least twice original size was 30 ± 15%. 
Expanded ICMs (n = 13) on tissue culture plates were isolated using two 27.5-gauge 
needles. These were seeded on mitotically-inactivated mEFs in medium 
supplemented with 10 ng/ml fLIF, 10 ng/ml hLIF, 3 µM GSK3 inhibitor plus 1 µM 
MEK and 10 µM ROCK inhibitors (Stemgent). After first single cell passage of the 
initial outgrowths, the percentage of colony formation (colony formed per ICM) was 
10 ± 9%. Cells were disassociated as single cells using Accutase (Innovative Cell 
Technologies) and seeded onto mitotically-inactivated mEFs. Cells were maintained 
in a humidified incubator (Thermo Fisher Scientific) (37°C, 5% CO2 in air) for 4 to 6 
days or until colonies occupied 30% to 40% of the well surface area. Colonies were 
then disassociated as single cells by Accutase and split (ratio of 1,3 to 1,4). Cells 
were expanded in this manner until passage 10. 
Evaluation of propagated embryonic cells 
For transcript expression, ICMs were isolated from blastocysts using 30.5g 
needles to separate cells that were subsequently lysed using extraction buffer 
(Applied Biosystems). RNAs were isolated using a PicoCure RNA isolation kit 
(Applied Biosystems). After being collected using cell scrapers (Thermo Fisher 
Scientific), embryonic cells were centrifuged (200 g, 5 minutes) to produce a pellet 
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that was subsequently lysed using RLT buffer (Qiagen), RNA then was isolated using 
the RNeasy Mini Kit following the manufacturer’s instructions (Qiagen). 
Complimentary DNA was generated by reverse transcription of 100 ng of RNA using 
the Super Script III First Strand Synthesis System (Thermo Fisher Scientific). 
Complimentary DNA samples were amplified using GoTaq Green Master Mix 
(Promega) in an Eppendorf thermocycler.  
Genes selected for amplification and primer sequences are shown in Appendix 
Table 1. The amplification was performed for 5 minutes at 95°C followed by 32 
cycles for 30 seconds at 95°C, 30 seconds at 58°C, 1 minute at 72°C, and 1 cycle for 
5 minutes at 72°C for extension. Presence or absence of amplified genes was 
evaluated by imaging after gel electrophoresis. Fluorescence intensity of PCR 
products were analyzed using ImageJ for semi-quantification. Then 20 ng of each 
PCR product was amplified using a Big Dye Terminator V3.1 cycle sequencing kit 
(following manufacturer’s instruction; Applied BiosystemTM) and were sequenced 
using a 96-capillary 3730xl DNA Analyzer (Applied BiosystemTM). PubMed Gene 
and Genome were the reference databases of sequences (Pontius et al., 2007; Irizarry 
et al., 2012).  
For genotyping, cells were expanded in the same medium without mEF feeders 
for three passages. Genomic DNA was isolated using a Purelink Genomic DNA Mini 
Kit (Thermo Fisher Scientific) from these embryonic cells. Genomic DNA samples 
(10 ng/10 µl reaction system) were amplified using AmpliTaq Gold 360 Master Mix 
(Applies Biosystems) in an Eppendorf thermocycler.    
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Karyotyping cat embryonic cells 
Chromosome spreads (n = 21, 23, 28 for each cell line, respectively) from cat 
embryonic cells were prepared as previously described (Priscila et al., 2009). 
Chromosomes were stained using Hoechst 33342 (Invitrogen) at 1 µg/ml with 
subsequent imaging using a Leica DMI 6000 inverted fluorescent microscope (Latte 
et al., 1975). Cat genome contains 38 chromosomes (Ford et al., 1980).     
Statistical analysis 
Values presented for staining intensity are means ± SD. Nine single factor 
treatments and 17 combination factor treatments were tested. Each treatment group 
includes 3 to 4 ICM outgrowths. Transcriptional expressions are normalized to 
RPL17 expression. Data were analyzed using a generalized linear mixed model 
(McDonald et al., 2014) in SAS University Edition with statistical significance set at 
P < 0.05. To select the best growth factor and inhibitor cocktail, average Euclidean 
distance between each treatment group and the ICM control group was calculated in 
Perl 5.8.8. A three-dimensional scatter plot diagram for each ICM outgrowth was 
generated via an IBM SPSS program.  
2.4 Results 
Presence of pluripotency markers and signaling components in the ICM 
Right after the removal of zona, blastocysts collapsed, and re-expanded on day 1. 
Half of the blastocysts attached to the feeder cells by day 2. About 80% blastocysts 
built attachment with feeders by day 4; the blastocyst outgrowths unattached by day 4 
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remained intact and detached to the end of culture. Those attached on mEF feeders 
expanded further with a dark inner cell mass sitting on top (Fig. 2.1). Without growth 
factor supplementation, the cell number increased up to day 4 of culturing without 
cytokines and declined from day 5. The cell number change indicated cell proliferation 
up to day 4 and cell differentiation or degeneration from day 4 (Fig. 2.2A). NANOG 
staining co-localized with the nucleus staining. NANOG intensity declined during the 
culturing. From day 4, NANOG intensities in the ICM outgrowths were significantly 
lower than that in blastocyst control, which correlated with cell number change in ICM. 
The loss of NANOG was either due to differentiation or cell degeneration. On day 6, 
a vague and duller green fluorescence was shown in the cytoplasm and cellular 
membrane, suggested that this is artifact, not true NANOG staining (Fig. 2.2B, 
Appendix Fig. 5). POU5F1 was stained in the nucleus like NANOG. The level of 
POU5F1 remained similar to blastocyst control until Day 4. The large variance of 
staining intensity showed that some of the cells had very low POU5F1 on Day 4, and 
POU5F1 levels decreased significantly like NANOG from Day 5. The artifact 
fluorescence was similar with what has been observed in NANOG (Fig. 2.2C, 
Appendix Fig. 5). SOX2 was stained in the nucleus as other two transcription factors. 
It decreased significantly from day 3 of culturing. Artifact observed on day 6 in the 
whole blastocyst outgrowths was consistent with the other channels. SOX2 declined 
faster than NANOG and POU5F1 (Fig. 2.2D). 
The pluripotent-related proteins NANOG, POUF5F1 and SOX2 were detected in 
blastomeric nuclei of expanded cat blastocysts (Fig. 2.3A). POU5F1 was more 
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restricted to the ICM compared to NANOG and SOX2 that were prevalent in 
trophectoderm nuclei as well.  
Transcripts of pluripotent-related genes (NANOG, POU5F1, SOX2, KLF4 and 
CMYC) were also expressed in the ICM (Fig. 2.3B). Signaling components in the 
FGF2 pathway (FGF2-receptor, MEK and ERK transcripts) were highly expressed 
compared to low levels of LIF-receptor and STAT3 transcripts in the LIF pathway of 
the ICM (Appendix Fig. 1). Activin A-receptor was modestly expressed in the ICM 
only, whereas other signaling components from the BMP and TGF/activin pathways 
(specifically BMP2-receptor and SMAD4 transcripts) were nearly absent (Fig. 2.3B, 
Appendix Fig. 1). Presence of BMP2-receptor and SMAD4 transcripts in fetal ovary 
validated the primers used for detecting these cat mRNAs. All PCR products were of 
the expected length (Appendix Table 1), upper band for NANOG was a larger 
transcript variant and upper band for ERK was a 5’-primer product with larger size. 
Bands at the bottom the lanes for CMYC and BMP2-receptor were unspecific, and 






Figure 2.1. Morphology change of blastocyst outgrowths in 6 days of culture without 
cytokine supplementations: blastocyst outgrowths expanded from day 1, attached to 







Figure 2.2.2 Blastocysts were cultured without cytokine supplementations for 6 days. 
A) Cell numbers in ICM outgrowths. Relative fluorescence intensity in cat ICM 
outgrowths of, B) NANOG; C) POU5F1 and D) SOX2. Fluorescence intensity values 
were relative to the average of control ICM. Values were expressed as mean ±standard 






Assessment of single growth factor supplementation on ICM outgrowths 
Because we detected signaling components in LIF/STAT3 and FGF2 pathways, 
ICMs were cultured for 6 days in medium supplemented with FGF2, human LIF or 
feline LIF at various concentrations. Cell numbers in ICM outgrowths were 
increased (P < 0.05) in most treatment groups after 6 days compared to the ICM 
control (Day 0) or control without growth factor (Day 6) (Fig. 2.4A). An exception 
that was not significant (P > 0.05) was treatment with 5 ng/ml FGF2.  
With the exception of supplementing with 10 ng/ml hLIF, other post-treatment 
results did not meet our ‘excellent’ classification, as defined in the methods, in 
sustaining NANOG. However, most treatments met our ‘good’ criteria at enhancing 
this protein (Fig. 2.4B). Three treatments (5 ng/ml FGF2, 1 or 10 ng/ml fLIF) were 
‘excellent’ at maintaining POU5F in ICMs while several supplementations (5 or 10 
ng/ml FGF2, 10 ng/ml hLIF, 1 or 10 mg/ml fLIF) were ‘good’ at preserving POU5F1 
(Fig. 2.4 C). Treatments with 5 ng/ml FGF2 or 100 ng/ml fLIF were ‘excellent’ at 
maintaining SOX2 in ICM outgrowths. Lastly, all three growth factors were capable 
of stimulating ‘good’ to ‘excellent’ results for SOX2 for at least one of the 
concentrations tested (Fig. 2.4D). However, not a single factor maintained all three 






Figure 2.3. Presence of pluripotency proteins and expression of genes related to 
pluripotency and signaling in the inner cell mass (ICM) of cat blastocysts.  A) Whole 
blastocyst immuno-staining of major pluripotency markers, chromatin (a), NANOG 
(b), POU5F1 (c), SOX2 (d). Quantified areas in ImageJ are displayed above 
fluorescence images. B) RT-PCR detection of pluripotent and signaling component 
mRNAs in ICMs, fetal ovary and cat fetal fibroblasts (CFFs), lanes were numbered as 
follows, DNA ladder, NANOG (1), POU5F1 (2), SOX2 (3), KLF4 (4), CMYC (5), LIF-
receptor (6), STAT3 (7), FGF2-receptor (8), MEK (9), ERK (10), Activin A-receptor 





Figure 2.4. Characterization of inner cell mass (ICM) outgrowth cultured in vitro for 
6 days with single growth factors (FGF2, hLIF, fLIF) at different concentrations. 
Positive controls were ICM in expanded blastocysts on Day 0 of culture (ICM).  
Other control groups were ICM outgrowths cultured for 6 days without growth factor 
supplementation (Control D6).  A) Cell numbers in ICM outgrowths.  Relative 
fluorescence intensity in cat ICM outgrowths of, B) NANOG; C) POU5F1; and D) 
SOX2. Fluorescence intensity values were relative to the control ICM. Values were 
expressed as mean ±  standard deviation (N = 4-5 replicates); * above the bars 
indicates a difference (P<0.05) from ICM; △ above the bar indicates a difference (P < 
0.05) from Control D6. 
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Assessment of combinations of growth factors and inhibitors on ICM outgrowths 
We formulated combinations of growth factor treatments based on testing of 
single cytokines (above) that resulted in ‘good’ or ‘excellent’ results as defined in the 
Material and Methods. Thus, we evaluated two to four factor-containing cocktails 
comprised of fLIF at 1, 10, 20 or 100 ng/ml with hLIF at 1, 10 or 100 ng/ml and/or 
FGF2 at 5 and 10 ng/ml (Table 2.1). All combinations, except Treatment 2, increased 
(P < 0.05) cell number in ICM outgrowths (Fig. 2.5A) compared to control Day 6. 
‘Excellent’ treatments for NANOG were combinations no. 11, 12, and 17 (Fig. 
2.5B). For POU5F1, ‘excellent’ treatments were combinations no. 4, 5, 9 and 17 
(Fig. 2.5C). For SOX2, ‘excellent’ treatments were combinations 9, 14 and 17 (Fig. 
2.5D). NANOG, POU5F1 and SOX2 intensities were increased (P < 0.05) compared 
to Control D6 in most of the treatments, although no combination sustained (P < 
0.05) all three protein expressions compared to ICM (Fig. 2.5). 
To better illustrate the capacity of each treatment to collectively sustain 
production of all three protein markers, relative intensities of each in individual ICM 
outgrowths were plotted three-dimensionally (Fig. 2.6). One treatment in particular 
was highly similar to the ICM control, 10 ng/ml feline LIF plus 10 ng/ml human LIF 
plus 3 μM GSK3i plus 1 μM MEKi (Treatment 17) giving the shortest Euclidean 
mean. This combination then was selected for further propagation of embryonic cells 














Figure 2.5. Characterization of inner cell mass (ICM) outgrowths cultured in vitro for 6 days with combinations of growth factors 
(FGF2, hLIF, fLIF) at different concentrations and inhibitors (GSK3i and MEKi). Combinations are detailed in Table 2.1. Positive 
controls were ICM in expanded blastocysts on Day 0 (ICM). Other control groups were ICM outgrowths cultured for 6 days without 
growth factor supplementation (Control D6).  A) Cell numbers in ICM outgrowths.  Relative fluorescence intensity in cat ICM 
outgrowths of: B) NANOG; C) POU5F1; and D) SOX2. Fluorescence intensity values were relative to the control ICM. Values were 
expressed as mean ± standard deviation 
 (N = 3-4 replicates); * above the bars indicates a difference (P<0.05) from ICM; △ above the bar indicates a difference (P < 0.05) 









Figure 2.6. Scatter plot of individual ICM outgrowths positioned by relative intensities of proteins. Individuals in ICM group 
and selected treatment group No. 17 (fLIF 10 ng/ml + hLIF 10 ng/ml + GSK3i 3 µM + MEKi 1 µM) with smallest Euclidean 












Propagation of embryonic cells with feline and human LIF plus GSK3i and MEKi 
Through 10 passages, colonies exhibited dome to flat shape morphologies 
(Fig. 2.7A) indicating that cells were stabilized. Genotyping of cells that formed 
colonies confirmed derivation from cat ICM outgrowths and not from mEFs used 
as feeder cells (Fig. 2.7B). More than 80% of cells from colonies (24/28, 19/23, 
17/21) had normal chromosome numbers (N = 38, Fig. 2.7C).  
All three proteins were present in embryonic cells after 10 passages, whereas 
NANOG and POU5F1 was detectable, but with lower intensity (Fig. 2.7D, Fig. 
2.8B). The overall transcript profiles between ICM and embryonic cell passage 10 
were similar (P> 0.05) (Fig. 2.8A, Appendix Fig. 1). Messenger RNAs of NANOG, 
POU5F1, SOX2, FGF2 receptor, MEK and ERK in embryonic cells remained at 
comparable levels to ICM controls. KLF4, CMYC and LIF-receptor decreased 
whereas STAT3 increased (Fig. 2.8A; Appendix Fig. 1). Messenger RNA levels of 
Activin A-receptor, BMP2-receptor and SMAD4 were unchanged compared to ICM 
(Fig. 2.8A, Appendix Fig. 1). However, intensity levels of NANOG and POU5F1 
were decreased (P < 0.05) compared to the ICM control (Fig. 2.8B). Embryonic 
cells generated from expanded ICM maintained many pluripotency-related features 




Figure 2.7. Characteristics of ICM outgrowths and derived cells at different passages.  
A) Morphologies of embryonic cells at different passages, passage 1 (a), passage 2 (b), 
passage 10 (c). B) Genotyping for cat fetal fibroblast (CFF), mouse embryonic 
fibroblast (mEF) and cat embryonic cell at Passage 2 (EC P2) and Passage 10 (EC 
P10). C) Karyotype of cat embryonic cells. D) Expression of major pluripotency 
markers in colonies at Passage 10, chromatin (a), NANOG (b), POU5F1 (c), SOX2 (d) 












Figure 2.8. Gene expression in ICM outgrowths and derived cells after 10 passages (EC P10). A) RT-PCR detection of transcript expression 
for pluripotent and signaling components, lanes were numbered as follows, DNA ladder, NANOG (1), POU5F1 (2), SOX2 (3), KLF4 (4), 
CMYC (5), LIF-receptor (6), STAT3 (7), FGF2-receptor (8), MEK (9), ERK (10), Activin A-receptor (11), BMP2-receptor (12) and SMAD4 
(13). RPL17 (14) was used as a reference gene, and cat ICM cDNA was used as a positive control. B) Relative intensities of immuno-staining 





All the proteins markers were stained in nucleus, like mouse and human (Tesar 
PJ, 2005; Wang et al., 2012), which agreed with their roles in regulating gene 
expressions during early embryo development. My hypothesis was validated by the 
decreased NANOG, POU5F1, SOX2 and cell numbers. The presence and enrichment 
of these three proteins in the beginning of the culture, and their elimination in the end 
of culture proved that they could be used as markers to assess pluripotency. Collective 
results suggested ICM cells in blastocysts neither remained pluripotent nor 
proliferative after 6 days of culturing in medium without cytokine supplementation. It 
helped setting up the time end point to assess the effect of cytokines in maintaining 
cell protein markers and cell proliferation. Low levels of LIF-receptor and STAT3 
expressions in cat ICMs may convey a modest activity of LIF/STAT3 signaling, 
resulting in inconsistent levels of phosphorylated STAT3, which is stimulating 
NANOG, POU5F1, and SOX2 expressions (Do et al., 2013). The absence of 
detectable transcript for BMP2-receptor and SMAD4, and decreased levels of LIF-
receptor as well as STAT3 in the cat ICM indicated pluripotency regulatory machinery 
that appeared unique to this model system (James et al., 2005). 
As measured in the mouse and human (Tesar, 2005; Tesar et al., 2007; Guo et 
al., 2016), LIF sustained NANOG, POU5F1 and SOX2 in the cat ICM. Yet, the 
impact of LIF was insufficient to sustain transcription factors at levels similar to that 
observed in the ICM control. This is consistent with what has been previously 
reported (Gomez et al., 2010; Yu et al., 2008). However, we observed variable 
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effectiveness between human LIF and feline LIF on transcription factor levels. The 
two proteins human LIF and feline LIF have similar amino acid composition 
(164/180, respectively; 91.1% sequence identity). Given the fact that human LIF can 
work at close efficiency to mouse LIF in maintaining mouse ESCs (with sequence 
identity ~90%) (Youngblood et al., 2014), human and feline LIF are assumed to have 
similar effect on cat ICM outgrowths. Yet, the responses of NANOG, POU5F1 and 
SOX2 were different in the treatment groups with feline LIF and human LIF. The 
reason is not clear and will require further investigations. Low levels of LIF-receptor 
and STAT3 expressions in cat ICMs may convey a modest activity of LIF/STAT3 
signaling, resulting in inconsistent levels of phosphorylated STAT3, which is 
stimulating NANOG, POU5F1, and SOX2 expressions. LIF/STAT3 pathway might 
not be the major mechanism maintaining pluripotency in the cat. Other pathways 
could be playing a regulatory role, for example, an inhibitor of GSK3 or a WNT3 
analogue, both of the latter known as supportive to maintaining mouse ESC in the 
absence of exogenous LIF (Sato et al., 2004). FGF2 supplementation alone also was 
unable to maintain NANOG, POU5F1 and SOX2 expressions. This was in contrast 
to studies of the human ESC (Eiselleova et al., 2009; Thomson et al., 1998) showing 
that FGF2 alone would support ESCs at a stable pluripotent state. We also observed a 
trend of increasing cell number, and decreasing transcription factors in ICM 
outgrowths, with ascending FGF2 concentration. It is likely that FGF2 might be 
serving as a proliferation enhancer and a pluripotency repressor within the cat ICM. 
This could be consistent with what has been observed in mouse ESCs where FGF2 is 
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known to stimulate active MEK1 suppressing the expression of Nanog (Santostefano 
et al., 2012; Sarabipour et al., 2016). Single factor treatments lead to variable 
responses. It is known that overexpressing OCT4 or SOX2 will lead to cell fate 
decision (OCT4 - mesendoderm lineage, SOX2 - neural ectodermal lineage) 
(Thomson et al., 2011). The changing pattern of OCT4 and SOX2 was observed in 
our culture system, which implied an unstable balance among NANOG, POU5F1 
and SOX2 within a given ICM outgrowth, and might lead to a loss of pluripotent 
state (Thomson et al., 2011).  
To better illustrate the capacity of each treatment to collectively sustain 
production of all three protein markers, relative intensities of each in individual ICM 
outgrowths were plotted three-dimensionally (Fig. 8). One treatment in particular was 
highly similar to the ICM control, 10 ng/ml feline LIF plus 10 ng/ml human LIF plus 
3 μM GSK3i plus 1 μM MEKi (Treatment 17) giving the shortest Euclidean mean. 
This combination then was selected for further propagation of embryonic cells derived 
from ICM outgrowths. 
Based on initial findings, we tested multiple cytokine combinations on cat ICM 
outgrowths over a 6-day culture. To stabilize the balance of pluripotency, we 
supplemented the culture medium with GSK3 and MEK inhibitors. Some treatments 
(No. 4, 5, 9, 12, 14, 16, 17) maintained pluripotency markers at levels similar to the 
control ICM group. Nonetheless, we did not prove our original assumption that 
supplementations that resulted in the highest similarity in NANOG, POU5F1 and 
SOX2 levels would produce normal, extended pluripotency and proliferation. The 
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impact of adding cytokines targeting different pathways resulted in enhanced cell 
proliferation and transcription factor response, yet in no case supporting NANOG, 
POU5F1 and SOX2 at a normal level. However, the use of a Euclidean means 
assessment assisted in identifying those treatment groups producing a result 
approximating the ICM control. The most promising results were generated with the 
supplementation of LIF combined with the GSK3 and MEK inhibitors. Specifically, 
we demonstrated that adding the MEK inhibitor promoted the rapid proliferation of 
cat embryonic cells. Similar to what has been observed in rodents (Czechanski et al., 
2014; Li et al., 2008); inhibiting MEK/ERK pathway did not compromise ESC 
growth. The morphology of the resulting cell colonies remained consistent from 
passage 2 to 10; implying decreased levels NANOG, POU5F1 and SOX2 did not 
lead to differentiation. The good expansion of stabilized embryonic cells then 
enabled us to evaluate certain pluripotent features, including the maintenance of 
transcription factors and signaling components supporting pluripotency. The 
combined cytokine treatment has boosted STAT3 which is essential in pluripotency 
stabilization (Do et al., 2013). Our observation of decreased KLF4, CMYC and LIF-
receptor transcripts in cultured embryonic cells suggested that cell status may have 
been compromised. Furthermore, reductions in NANOG, POU5F1 and SOX2 
intensity by passage 10 showed that the protein expressions were not directly 
equalized to rising mRNA levels. Mouse studies have conclusively demonstrated the 
need for sustained levels of NANOG, POU5F1 and SOX2 proteins to promote 
pluripotency (Rodda et al., 2005). By contrast, our observation in cat embryonic cells 
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probably was indicating a loss of pluripotency with advanced passages. 
Consequently, we cannot conclude that our selected cytokine combinations had the 
capacity to sustain embryonic cells to a state analogous to ESCs reported in other 
studies (Czechanski et al., 2014; Li et al., 2008; Guo et al., 2016). 
Our cat model confirms that there is complexity in regulating NANOG-
POU5F1-SOX2 circuitry, not only due to the doses need to target hundreds of ESC 
hallmark genes (Wang et al., 2012), but also to their positive/negative feedback loop 
in regulating each other (Rodda et al., 2005). Certainly, the dynamism we observed 
in the cat ESC system indicated that there was no simple cytokine formula for 
perpetuating cell pluripotency. Deviations in signaling pathways and cellular fate 
may be related to natural differences among species in modes of embryo 
development preimplantation. This already is apparent from the notable disparities in 
timing and signaling requirement in mouse versus human (Czechanski et al., 2014; 
Guo et al., 2016). Whereas a mouse blastocyst implants at approximately embryonic 
Day 4.5 (E4.5) (Schrode et al., 2013), the human counterpart embeds at E 7-10 
(Wilcox et al., 1999). Then more specifically in terms of mechanisms, the human 
epiblast experiences a highly expressed transforming growth factor-β (TGFβ) 
pathway (Blakeley et al., 2015) (e.g., nodal) that, if inhibited, down-regulates the 
core pluripotency factor NANOG (James et al., 2005). However, this identical 
manipulation in the mouse has no discernible influence on the same metrics (James 
et al., 2005), again demonstrating a remarkable species variation in pluripotency 
regulation. Therefore, given that the cat embryo has a comparatively long 
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preimplantation embryo development period and that the cat blastocyst proceeds to 
gastrulation before implantation (at E13-14) (Knospe 2002), it probably explains 
why the mouse protocol for sustaining pluripotency in embryonic cells was not 
translatable to the cat.  
Our findings help to explain the loss of pluripotency observed in previous 
studies attempting to create viable cat ESCs (Gomez et al., 2010; Yu et al., 2008). We 
demonstrated that, unlike for the mouse and human, LIF or FGF2 solely could not 
support NANOG, POU5F1 and SOX2 expressions. Those findings plus the absence 
of detectable transcript for BMP2-receptor and SMAD4, and decreased levels of LIF-
receptor as well as STAT3 in the cat ICM indicated pluripotency regulatory 
machinery that appeared unique to this model system. To sustain pluripotency in cat 
ESCs, the nature of cat early embryos needs to be further investigated. For instance, 
the dynamics of LIF- receptor, STAT3, and the Interleukin 6 (IL6) family need to be 
drawn, and the control elements on these factors have to be revealed. The relation 
between featured signaling pathways (LIF/IL6/STAT3, FGF2/MEK/ERK, etc.) and 
embryonic stage (4-cell, morulae, inner cell mass) would contribute to a deeper 
understanding of pluripotency. Furthermore, time-lapse transcriptome and proteome 
analysis in cat embryos up to blastocysts might be necessary to finely tune the 
culture conditions. 
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Chapter 3 Reprogramming cat fetal fibroblasts using inducible transcription 
factors 
3.1 Abstract 
Pluripotent stem cells have great value, both in clinical and basic research, and 
for endangered species conservation. In the cat model, establishment of induced 
pluripotent stem cells (iPSC) have several advantages over the embryonic stem cell 
(ESC), 1) fibroblasts are readily available in contrast to the limited supply of embryos, 
and 2) expression of transcription factors can be manipulated to reprogram and 
maintain the cells in a pluripotent state. In our study, efficiency of induction using five 
transcription factors (NANOG, POU5F1, SOX2, KLF4 and CMYC) was assessed. A 
tet-on system was integrated into cat fetal fibroblasts to control the transgene 
expression. Cells were cultured in DMEM/F12 supplemented with LIF and 2i (GSK3 
and MEK inhibitors). Forced expression of the transgenes led to increased expression 
of endogenous NANOG, POU5F1, SOX2, and acquisition of stem cell characteristics. 
Colonies with a dome shape and clear border were selected after two weeks of 
treatment. A portion of these colonies stained positive for alkaline phosphatase (0.002% 
per fibroblasts seeded). After silencing the transgenes by removal of doxycycline, the 
stem cell characteristics were sustained independently. While detectable, the relative 
intensities of NANOG, POU5F1, and SOX2 following immuno-staining were lower 
than that in inner cell mass (0.2, 0.19, and 0.45 vs. 1.0, respectively) and remained at 
similar levels over 40 days of culture. The reprogrammed cells proliferated rapidly and 
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could be expanded over 10 passages and form embryoid bodies. Colonies had mixed 
staining patterns for alkaline phosphatase, transcription factors, and morphologies. 
Expression levels of differentiation markers increased in iPSCs over time, implying 
that while some of the colonies were pluripotent-like, other colonies might undergo 
differentiation. 
3.2 Introduction 
Induced pluripotent stem cells (iPSCs) are considered indistinguishable from 
embryonic stem cells, in regard to their capacity of self-renewal and directed 
differentiation (Okita et al. 2007 and Maherali et al. 2007). The process of 
transforming differentiated somatic cells into undifferentiated pluripotent stem cells is 
defined as reprogramming, which was first accomplished by forced expression of four 
transcription factors (POU domain, class 5, transcription factor 1 (POU5F1 aka OCT4), 
Sex determining region Y box 2 (SOX2), Kruppel-like factor 4 (KLF4) and 
myelocytomatosis proto-oncogene protein (CMYC)) in mouse fibroblasts (Takahashi 
and Yamanaka 2006). The establishment of iPSC lines in mouse and human, by 
different research groups shows that this method to produce stem cells is highly 
repeatable (Haase et al., 2009; Hockemeyer et al., 2008; Lu et al., 2011; Nakagawa et 
al., 2008). While only limited success has been reported in domestic and companion 
animals, such as dogs, pigs, cattle, and horses (Brenton et al., 2013; Chakritbudsabong 
et al., 2017; Talluri et al., 2015；Whitworth et al., 2012), development of these 
techniques in non-rodent species is highly desirable for use in clinical, and basic 
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research. In the cat model, establishment of induced pluripotent stem cells (iPSC) has 
several advantages over the embryonic stem cell (ESC), 1) fibroblasts are readily 
available in contrast to the limited supply of embryos, 2) expression of transcription 
factors can be manipulated to reprogram and maintain the cells in a pluripotent state, 
and 3) individual specific lines can be made.  
The domestic cat is an invaluable model in biomedical research and conservation 
biology for which it serves as a model for the feline family (Johnson et al. 2006) and 
has been used in studies for reproduction (Hobbs et al. 2012). Partial success in 
reprogramming cells from wild felids has been reported in which five transcription 
factors including Nanog homeobox (NANOG) were used to generate the potential 
iPSCs (Verma et al. 2012 and 2013). This achievement relied on the high identity of 
transcription factors between human and cat and the conserved roles of the core 
transcription factors, NANOG, POU5F1, and SOX2, in acquiring pluripotency (Breton 
et al. 2013; Haase et al., 2009; Talluri et al., 2015; Takahashi and Yamanaka, 2006). 
The challenge with the wild feline studies was that two of the transgenes, human KLF4 
and CMYC, couldn’t be silenced (Verma et al. 2012 and 2013). In mouse and human 
continued expression of exogenous genes is not required for maintenance of iPSCs 
after reprogramming (Okita et al. 2008 and Soares et al. 2015). While these factors 
were required during initial reprogramming (Takahashi et al. 2007), continued 
expression of KLF4 (Hu et al. 2015) and CMYC (Lin et al. 2012) may increase 
tumorigenesis during differentiation, thus limiting the potential utilization of iPSCs for 
regenerative medicine. Generally, the transgenes are prone to systemic post-
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transcriptional gene silencing and DNA methylation (Jaenisch et al. 1981 and 
Dalakouras et al. 2011). The reason why human KLF4 and CMYC remained active in 
the wild feline is unknown, but this issue needs to be overcome for successful 
application of iPSC to clinical and conservation uses.  
We proposed using a drug-inducible system with reverse tetracycline- 
transactivator (rtTA) (Hockemeyer et al. 2008e) that would control the transgene 
expression efficiently. In our study, rtTA-M2, a mutant of rtTA which has increased 
stability and inducibility in the presence of doxycycline was used. This inducible 
activator was expected to have reduced background expression in the absence of 
doxycycline (tetracycline analog) (Urlinger et al., 2000). Moreover, we have identified 
a growth factor and inhibitor combination that maintains pluripotency-related proteins 
for ten passages in feline ESC-like cells (Chapter 2). This combination will aid in the 
generation of iPSCs. 
3.3 Materials and methods 
Approval from an Institutional Animal Care and Use Committee was not required 
as domestic cat gravid uteri, ovaries, and testes were obtained from local veterinarians 
following routine owner requested ovariohysterectomies or orchiectomies. These are 
exempt studies under Title 9, Code of Federal Regulations, Subchapter A- Animal 
Welfare, Part 1 to 3. Tissues from second-trimester fetuses were processed on the same 
day of collection. Cells were isolated and cultured as described for mouse embryonic 
fibroblasts in previous studies (Nagy A et al., 2002). After 48 hours of culturing, cells 
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were 100% confluent and were frozen for future usage. Frozen cat fetal fibroblasts 
(CFFs) were recovered and seeded 24 hours before transduction. 
Oocytes were collected and matured for 24 hours with FSH and LH, then 
fertilized by motile sperms at 1x106/ml for 24 hours. Embryos were cultured for 7-9 
days until expanded blastocyst stage at 38.5 ℃, 6% CO2. Inner cell mass (ICM) cells 
were obtained by manual dissection from in vitro produced blastocysts as previously 
described (Chapter 2).  
Transduction of CFFs 
Lenti-XTM 293T cells were maintained following the manufacturer’s instructions 
(Clontech). The 293T cells (80% confluent) were split 1,2 into 10 cm tissue culture 
plates 24 hours prior to transfection and transfected with plasmids containing human 
NANOG; POU5F1; SOX2; KLF4 and CMYC (Addgene). Briefly, 5µg of plasmid of 
pFUW-M2rtTA or pFUW-tetO-transcription factor along with pCMV-dR8.2 dvpr and 
pCMV-VSV-G at a ratio of 2,2,1 was mixed with 15 µl PolyJetTM in vitro DNA 
transfection reagent following the manufacturer’s instructions (SignaGen Laboratories, 
Addgene, https//www.addgene.org/viral-vectors/lentivirus/lenti-guide and 
https//www.addgene.org/tetracyclin). After 12 hours of transfection, medium for 293T 
cells was replaced by 10ml Dulbecco's Modified Eagle Medium (DMEM, Life 
Technologies) with 20% HyClone defined fetal bovine serum (DFBS, GE Healthcare 
Life Sciences), and 1 mM L-Glutamine (Life Technologies). Medium from each plate 
was collected after 48 hours of incubation with transfected 293T cells and centrifuged 
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at 500g for 8 minutes. CFFs around 40% confluent were transduced using a modified 
protocol for reprogramming human somatic cells (Hockemeyer et al. 2008).  Ten ml 
of the combined viral prep supernatant was mixed with 4 µg/ml hexadimethrine 
bromide (Sigma) and added to each 10cm plate of CFFs for 24 hours. On day 0, CFFs 
were transduced by virus mix for rtTA and human NANOG; on day 1, CFFs were 
transduced by virus mix for human POU5F1 and SOX2; on day 2, CFFs were 
transduced by virus mix for human KLF4 and CMYC. On day 3, medium for CFFs 
was replaced by 10 ml DMEM with 10% FBS and 1mM L-Glutamine. Doxycycline 5 
µg/ml was added from day 4. Medium was replaced every two days until the first 
colony with a clear border was observed. CFFs were incubated with 10 ml of StemFlex 
medium (ThermoFisher Scientific) with feline LIF 10ng/ml, human LIF 10ng/ml, 
GSK3 inhibitor 3 µM, MEK inhibitor 1 µM, ROCK inhibitor 10 µM (Chapter 2) and 
doxycycline 5 µg/ml for 28 days. Mouse embryonic fibroblasts (MEFs) were 
transduced and culture using the same procedures as a positive control. High alkaline 
phosphatase activity is considered a characteristic of stem cells and is useful for initial 
screening of potential iPSC. Transduced CFFs and MEFs were stained every two days 
from day 10 to 32 for alkaline phosphatase activity using alkaline phosphatase (AP) 
live stain (Thermo Fisher).  
Expanded culture of potential iPSCs 
Colonies with a dome shape and clear edge were selected for isolation by a glass 
scalpel (Verma et al. 2013), placed on mitomycin-inactivated CFFs (Gomez et al. 
2010). Colonies were allowed to attach to the feeder cells for three days, then cells 
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were disassociated by Accutase (Innovative Cell Technologies) and seeded onto 
inactivated CEFs. Cells were maintained in a humidified incubator (Thermo Fisher 
Scientific) (37°C, 5% CO2 in air) until colonies occupied 40 – 50 % of the well surface 
area (every two to three days). Colonies were then disassociated by Accutase and split 
(ratio of 1,3 to 1,4). Doxycycline was withdrawn from passage 2. Cells were expanded 
until passage 10. Colonies then were disassociated with Accutase and one million cells 
were suspended in 2 ml medium, and each hanging drop was of 25μl cell suspension. 
Embryoid bodies were collected from Day 2 from the hanging-drop and cultured in 
petri dishes in StemFlex medium without growth factors, but with 10μM retinoid acid, 
for six days (Appendix Figure 3). 
Fluorescent Immunocytochemistry (ICC) 
Expression of protein markers of pluripotency in the putative iPSC was assessed 
using immunocytochemistry. Cells were fixed by 4% paraformaldehyde (PFA) in PBS 
at room temperature (10 minutes) and then rinsed twice with 1x DPBS (5 minutes, 
Sigma). Fixed cells were permeabilized 0.2% Triton X-100 and 0.1% Tween 20 in PBS 
at room temperature (10 minutes), then rinsed twice in TBS with 0.05% Tween 20 (5 
minutes). Cells were rinsed with PBS, and then blocked with Maxblock Blocking 
Medium (Active Motif) at 4°C (overnight). Cells were incubated with the primary 
antibodies (anti-human NANOG [500-P236; Peprotech], anti-human POU5F1 
[MAB4401; Millipore] and anti-human SOX2 [SC1002; Millipore] at 1.5 µg/ml) in 
Maxbind Staining Medium (Active Motif) at 4°C (overnight) with gentle rocking. 
Cells were rinsed with Maxwash Washing Medium (5 minutes, Active Motif) three 
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times. Cells were then incubated with the secondary antibodies (Alexa Fluor 488 goat 
anti-rabbit IgG [H+L], Alexa Fluor 647 goat anti-mouse IgG1, Alexa Fluor 594 goat 
anti-mouse IgG2a (Thermo Fisher Scientific) at 1 µg/ml] in Maxwash Washing 
Medium at room temperature (1 hour, in the dark) with gentle rocking. Cells were 
rinsed with Maxwash Washing Medium four times (5 minutes each). Hoechst 33342 
(Invitrogen) was added during the third wash at 1 µg/ml to stain nuclei. Imaging was 
done using a Leica DMI 6000 inverted fluorescent microscope. Fluorescence 
intensities were analyzed using ImageJ for semi-quantification of proteins (NANOG, 
POU5F1 and SOX2). Intensities of each stained proteins were normalized to the 
average intensity in ICMs in Day 7 to 9 blastocysts as positive controls (Nestle et al., 
2012). Two negative controls were used 1) non-transfected CFFs cultured in the same 
StemFlex medium with the same supplementations and 2) immunostaining with 
secondary antibody only (Appendix figure 4). Transduction rate was calculated using 
ImageJ, by the ratio of cell number with green fluorescent protein staining to total cell 
number with nucleus staining.  
RT-PCR and RT-qPCR analysis  
For reverse transcription-polymerase chain reaction (RT-PCR) and RT-
quantitative PCR (RT-qPCR) analysis, cells were lysed using extraction buffer 
(PicoPure RNA isolating kit, Applied Biosystems). RNAs were extracted with DNA 
removal treatment on columns following the manufacturer’s instruction (PicoPure 
RNA isolation kit, Applied Biosystems). 
Complimentary DNA was generated by reverse transcription of 50 ng of RNA 
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using SuperScript IV VILO Master Mix (Thermo Fisher Scientific). For transgene 
expression analysis, cDNA samples were amplified using GoTaq Green Master Mix 
(Promega). For endogenous gene expression analysis, cDNA samples (3 biological 
replicates for each passage) were amplified using QuantiFast SYBR Green Master Mix  
(Qiagen) in a BioRad CFX96 real-time PCR system. Genes selected for amplification 
and primer sequences are shown in Appendix Table 1. The quantitative PCR 
amplification was performed for 5 minutes at 95°C followed by 40 cycles for 10 
seconds at 95°C, 30 seconds at 60°C. Triplicate of Cq values were analyzed by 
Comparative Cq method (2-ΔΔCT) to reference gene RPL17, which was validated in a 
previous study (Penning et al., 2007). Reverse transcription minus controls (from RNA 
products in iPSC at passage 3, 6 and 10) were included in the reactions. Each PCR 
product (20 ng) was amplified using a Big Dye Terminator V3.1 cycle sequencing kit 
(following manufacturer’s instruction; Applied BiosystemTM) and were sequenced 
using a 96-capillary 3730xl DNA Analyzer (Applied BiosystemTM). PubMed Gene 
and Genome were the reference databases of sequences (Pontius et al. 2007 and 
Irizarry et al. 2012).  
For genotyping, genomic DNA (3 biological replicates) was isolated using a 
Purelink Genomic DNA Mini Kit (Thermo Fisher Scientific) from CFFs, transduced 
CFFS and iPSCs. Genomic DNA samples (10 ng/10 µl reaction system) were 
amplified using AmpliTaq Gold 360 Master Mix (Applies Biosystems) in an 
Eppendorf thermocycler. CFF transduced with transcription factors were used as 
positive controls, CFFs were used as negative controls. 
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Karyotyping   
Chromosome spreads (n = 29, 38, 25 for each cell line at passage 10, respectively) 
prepared as previously described (Priscila et al. 2009). Chromosomes were stained 
using Hoechst 33342 (Invitrogen) at 1 µg/ml with subsequent imaging using a Leica 
DMI 6000 inverted fluorescent microscope (Latt et al. 1975).  
Statistical analysis 
Values presented for staining intensity are means ± S.D. Protein levels are 
normalized to the mean of ICM proteins. Transcriptional expressions are normalized 
to RPL17 expression (△Cq), and then relative to a reference (△△Cq). Data were 
analyzed using a generalized linear mixed model in SAS University Edition with 
statistical significance set at P < 0.05.  
3.4 Results 
The transduction efficiency by pseudo lenti virus was over 90% in CFFs (Fig. 
3.1A), the majority of cells were stained positive for NANOG, POU5F1 and SOX2. 
The first colony stained AP positive in cat appeared on day 13 of doxycycline induction, 
a week later than mouse colony formed (Fig. 3.1B). Only 10% of colonies were AP 
positive. The accumulation of AP positive colonies in MEFs was faster than in CFFs. 
The overall colony formation rate was 0.002% (8 out of 5 x 105 cells seeded) for CFFs, 
much lower than mouse (0.02%, 101 out of 5 x 105 cells seeded) (Fig. 3.1C). The 
colony morphologies were similar between mouse and cat.  
Within 3 days after withdrawal of doxycycline at passage 2, the transgenes were 
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silenced (Fig 3.2). This result was validated by quantitative PCR for transgene 
expressions in pooled iPSC samples from each passage. Colonies selected under 
doxycycline were dissociated into single cells and daughter colonies were formed 
without doxycycline (Fig. 3.3A). Cells proliferated rapidly such that colonies needed 
to be passaged every two to three days. Morphologies of colonies were similar in 
different passages. These colonies were stained positive for NANOG, POU5F1 and 
SOX2 (Fig. 3.3A), yet the levels of the three proteins were much lower than those in 
ICM (P< 0.05, Fig. 3.3B), except for SOX2 in iPSC passage 6 and 10. The intensity 
levels of individual proteins were different between colonies (Fig. 3.3A). Furthermore, 
AP positive levels varied between different colonies in the same passage, around 50% 





Figure 3.1. A) The expression of rtTA was confirmed by tet-on GFP in control CFFs 
and transduced CFFs, control CFFs and transduced CFFs (without tet-on GFP 
integration) after 7 days of Doxycycline induction were stained for NANOG, POU5F1 
and SOX2 (human and cat proteins were not distinguishable); B) The numbers of AP 
live positive colonies in transduced mEFs and CFFs along time; C) AP stain for 







Figure 3.2 Genomic PCR for human transgenes integrations, RT-PCR for human 
transgene expressions in cat iPSCs in different passages without Doxycycline 





Figure 3.3. A) AP stain, B) ICC stain for NANOG, POU5F1 and SOX2 in cat 
blastocysts, cat iPSC passage 3, 6 and 10; C) Relative quantification of NANOG, 
POU5F1, SOX2 levels by ICC in cat blastocysts, cat iPSC passage 3, 6 and 10. 
Fluorescence intensity values were relative to the average of control ICM. Left bottom 
corner images on blastocyst images were negative control without primary antibodies. 
Full size negative controls can be found in Appendix 4. Values were expressed as mean 
±standard deviation (blastocysts=4-5, iPSC biological replicate =3, 5 colonies in each 
biological replicate). * P<0.05, compare to cat ICM in blastocysts. 
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The transcription patterns in CFFs and CFF-iPSCs were different (Appendix Fig. 
2). While NANOG, POU5F1 at passage 3 and 6 remained similar in iPSCs (P>0.05), 
in contrast to POU5F1 at passage 10, SOX2 (pluripotency markers) increased (P<0.05). 
CMYC decreased in iPSCs (P<0.05). SOX17 (endoderm markers), Brachyury, FOXF1 
(mesoderm markers), and PAX6 (ectoderm marker) increased in all iPSCs (P<0.05). 
SOX1 (ectoderm markers) increased at passage 3 and 6 (P<0.05) (Fig. 3.4 A). KLF4 
and REX1 (naïve state markers) expression varied between different cell lines at 
different passages, so the change was not significant (P>0.05) (Fig. 3.4A). FGF5 
(primed state marker) and GATA6 did not change significantly.  
When iPSC transcript amounts were compared relative to expression in ICM, 
NANOG was decreased in all cell lines regardless of passage number (P<0.05) (Fig. 
3.4B).  The apparent increase in POU5F1 and SOX2 in all three biological replicates 
regardless of passages was not significant (P>0.05) (Fig. 3.4B). KLF4 and CMYC 
levels did not change significantly (P>0.05) (Fig. 3.4B). REX1 decreased in all three 
iPSC cell lines (P<0.05) (Fig. 3.4B). Differentiation markers SOX1 decreased in iPSC 
passage 10, GATA6 decreased in all iPSCs (P<0.05) (Fig. 3.4B). There was obvious 
variation in differentiation markers. There was no detectable Brachyury (primed state 
and mesoderm marker) in ICM. Regarding the increased Brachyury compared to CFFs 
(which had low levels of Brachyury), it was clear that Brachyury was increased in 
iPSCs. The other differentiation markers, FOXF1, SOX17 and PAX6, which 
represented mesoderm, endoderm and ectoderm lineages respectively, were not 
changed significantly (P>0.05) (Fig. 3.4B). There was one cell line which at passage 
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3 showed overall low levels in lineage markers (P<0.05), and similar levels of 
pluripotency markers to later passages (P>0.05). However, levels of lineage markers 






Figure 3.4 A) Gene fold changes (2-
△△Cq) to CFFs in iPSCs at different passages (N=3 
biological replicates); B) Gene fold changes (2-
△△Cq) to ICM in iPSCs at different 





Cat iPSCs at passage 10 could form embryoid body-like cell aggregates after 1 
day of culture in hanging drops (Appendix Fig. 3). Pluripotency markers NANOG, and 
POU5F1 and SOX2 were decreased (P<0.05) in Day 6 EBs, compared to its origin 
iPSC at passage 10 (Fig. 3.5A). KLF4 did not change significantly (P>0.05), when 
each cell line showed various changes. FGF5 and CMYC were increased in all EBs 
(P<0.05) (Fig. 3.5A). REX1 was significantly lower (P<0.05) in all the EBs (Fig.3.5A). 
PAX6 (ectoderm) and FOXF1 (mesoderm) remained similar (P>0.05). The other 
lineage markers, Brachyury, GATA6, SOX17, and SOX1 declined (P<0.05) (Fig. 3.5A).  
When compared relative to ICM expression, lineage markers increased in EBs, 
including SOX17 (P=0.05), FOXF1 (P<0.05), and PAX6 (P<0.05), which were similar 
to what has been observed in late passage iPSCs (Fig. 3.4 B). Like the comparison to 
iPSCs, pluripotency markers NANOG, POU5F1, and SOX2 declined (P<0.05). 
However, KLF4 and CMYC rose significantly (P<0.05) (Fig. 3.5B). REX1 (naive state 
marker) was significantly lower (P<0.05). FGF5 was at reduced levels (P<0.05) as 
well. GATA6 and SOX1 were much lower (P<0.05) than that in ICM, while Brachyury 
was detected in EB, comparable to iPSC passage 10, but not in ICM.  
The percentage of normal karyotypes (N=38 chromosomes) ranged from 87% to 





Figure 3.5 A) Gene fold changes (2-
△△Cq) to iPSC P10 in EBs (N=3 biological 
replicates); B) Gene fold changes (2-





The generation of iPSCs in endangered species could have great therapeutic 
potential (Beevers et al. 2013; Lam et al., 2014, Verma et al. 2013). However, because 
exogenous KLF4 and CMYC remained active, successful establishment of fully 
reprogrammed iPSC in feline cells has not been achieved (Verma et al., 2012 and 2013).  
In this study, a lenti-viral based, drug inducible system (Hockemeyer et al., 2008) 
was used to generate potential iPSCs in the domestic cat in a more regulated manner. 
The control element rtTA and human transgenes, NANOG, POU5F1, SOX2, KLF4 and 
CMYC were successfully integrated into the cat fibroblast genome using pseudo-lenti 
viral transduction. This enabled controlled expression of human transcription factors 
in CFFs using doxycycline. While colony formation rate for reprogrammed CFFs was 
slower and at a lower efficiency than that of the MEF control (0.002% versus 0.02%, 
respectively), the colony formation rate was acceptable and similar to those obtained 
in canine studies (0.007%, Whitworth et al., 2012). Notably, unlike previous reports 
in the cat, colonies sharing partial pluripotent features could be maintained after the 
transgenes were silenced. Analysis of transcription markers in iPSCs found disparities 
between transcripts and protein expression levels for pluripotency markers. For 
example, POUF1 and SOX2 had higher transcriptional levels and lower protein levels 
compared to ICM.  Although not as extreme, other disparities were observed 
(Appendix Table 2), e.g., NANOG which had varying levels of transcript and protein 
in the CFF, iPSC and ICM. Such disparities between transcript and protein levels have 
been previously reported in goat embryos (He et al., 2006).  Taken together, the 
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iPSCs generated from this system shared partial features of its embryonic counterpart 
ICM, yet different from what has been generated from mouse and humans (Takahashi 
and Yamanaka, 2006; Takahashi et al., 2007).  
Comparing to what has been observed and validated in mouse, there were several 
issues to be addressed for this feline study. First of all, the reprogramming efficiency 
might be compromised in the cat, The reprogramming efficiency is relatively low in 
cat compared to mouse in this study (0.002% versus 0.02%); however, the amino acid 
sequence identities for the pluripotency transcription factors are similar for cat and 
mouse as compared to human (Pontius et al. 2007; Irizarry et al., 2012; Genebank, 
Pubmed). As the reprogramming efficiency for mouse in this study is similar to that in 
mouse studies using homologous transgenes (Takahashi and Yamanaka, 2006), this 
suggests that the minor difference in amino acid sequence did not compromise 
reprogramming in the cat and it may be that other factors that are affecting 
reprogramming efficiency in the cat.  
Secondly, pluripotency maintenance was insufficient in this system. After 
isolation of colonies that stained positive for AP, cells were allowed to expand on 
feeders, but AP levels started to vary in the daughter colonies. As alkaline phosphatase 
is a useful marker for selecting colonies that could exhibit other pluripotency features 
(Lu et al., 2011), this indicated that from early passage the pluripotency state was not 
stable. Within the time of culture, cat iPSC lines had already started to differentiate, 
which may explain why EBs did not express increased lineage markers compared to 
iPSC at passage 10. Notably, CMYC increased in EBs (fig 3.5). The increase of CMYC 
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might be a cellular response to enhance self-renewal and block differentiation during 
EB culture (Satoh et al., 2004). Although CMYC is dispensable in generating mouse 
and human iPSCs (Nakagawa et al., 2008), it was mainly used as an enhancer in this 
procedure (Araki et al., 2011, Verma et al. 2012). It is known that CMYC is context-
dependent in cell fate determination in progenitor cells (Wilson et al., 2004). As REX1 
was declining from early to late iPSC lines in our study, while CMYC was high and 
FGF5, Brachyury and other lineage markers were increasing, the role of CMYC in 
reprogramming and EB generation in the cat is not clear.   
One possibility affecting these issues is that the culture supplementation (LIF, 
GSK3i and MEKi), which was adequate for mouse ESCs and iPSCs (Czechanski et 
al., 2014; Takahashi and Yamanaka, 2006), but was not adequate for maintaining 
pluripotency in the cat and further improvements are needed (Chapter 2). In all, it is 
encouraging that pluripotent-like colonies could be generated in this drug-inducible 
system using human transcription factors. The colonies, though in an unstable state 
still showed partial features of pluripotency.  
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Chapter 4 Summary and Future directions 
4.1 Summary 
This project explored methods to improve the derivation of pluripotent stem cells 
in the domestic cat, as a model for endangered felids. Two approaches were taken, the 
first was to assess effect of cytokine combinations in maintaining NANOG, POU5F1 
and SOX2, as well as features of cellular pluripotency in ICM-derived embryonic cells, 
and the second was induction of pluripotency by forced expression of exogenous 
transcription factors in the same culturing supplementation formulated in the first study.  
In the first study on embryonic stem cells derivation, NANOG, POU5F1 and 
SOX2 were affirmed as pluripotency markers in cat embryos and its derivatives. Using 
RT-PCR, the presence of transcripts for genes in the LIF/STAT3, and FGF/MEK/ERK 
signaling pathways in cat ICM were validated. Therefore, growths factors targeting 
these two pathways were selected and assessed in sustaining pluripotency markers. As 
single growth factor supplementation alone could not maintain all three proteins at 
their original levels as in ICM, combinations of growth factors and selected inhibitors 
(GSK3 inhibitor and MEK inhibitor-2i) were evaluated for their capacity of sustaining 
NANOG, POU5F1 and SOX2. Similar with mouse ESCs, LIF, with 2i was the most 
effective cocktail in preserving these proteins. Colonies with morphology like mouse 
ESCs were generated from blastocyst outgrowths, sharing some of the pluripotent stem 
cell characteristics, including rapid self-renewal. However, decreased levels of 
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NANOG, POU5F1 and SOX2 implied that the cell state was not identical to in vivo 
counterparts (ICM).  
In the second study, pluripotency was acquired by forced expression of exogenous 
transcription factors in cat fetal fibroblasts. Owing to the beneficial effects observed 
in Study 1, a LIF and 2i combination was used to aid in reprogramming and colony 
expansion. As observed in cat embryonic cells, partial characteristics of pluripotency 
were sustained, in the form of fast proliferation, NANOG, POU5F1, and SOX2 
expression, as well as alkaline phosphatase, although at lower levels than would be 
expected in fully reprogramed cells. Notably, unlike previous reports in the cat, 
colonies sharing partial pluripotent features could be maintained after the transgenes 
were silenced. In addition to the protein and transcript markers for pluripotency, 
lineage marker dynamics were examined in ICM, iPSCs, and embryoid bodies. The 
outcome suggested the cells generated with LIF and 2i had developed beyond the 
undifferentiated stage of ICM in expanded blastocyst. Collective results not only 
challenged the efficacy of the cytokines combinations LIF and 2i in maintaining feline 
pluripotency, but also suggest the future direction of such research, in elucidating 
major mechanism in pluripotency regulation in cats. 
4.2 Future directions 
4.2.1 Investigating signaling pathways that regulate pluripotency in cats 
It is known that STAT3 signaling is highly active in mouse pre-implantation 
embryos (Do et al., 2013). In mouse oocytes, STAT3 is highly expressed and its 
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phosphorylation is necessary for pluripotency regulation. At 4-cell stage, STAT3 
becomes phosphorylated and translocates to nucleus (Do et al., 2013). STAT3 
phosphorylation firstly depends on LIF at 4-cell stage in all mouse strains. As embryos 
develop to blastocysts, this modification starts to rely on various members in 
Interleukin 6 (IL6) family, including LIF, Cardiotrophin-1 (CT1), and IL6, in different 
mouse strains (Do et al., 2013; Kabayashi et al., 2014; Shen et al., 2009). STAT3-null 
or STAT3-dephosphorylated embryos arrest before the pre-implantation stage (Do et 
al., 2013; Yin et al., 2014). The study on small molecules tested on bovine embryos 
also agreed that STAT3 activation has a positive impact on blastocyst formation (Meng 
et al., 2015), and no LIF-receptor transcripts were detected at the morula to blastocyst 
transition, which suggested there is another factor activating STAT3 (Eckert and 
Niemann, 1998). These studies showed that STAT3 is the core mediator in early 
embryo from different species, but LIF is not the only factor that regulates its 
phosphorylation. After implantation, the signaling pathway that regulates embryonic 
development switches to FGF/MEK and Nodal in mouse (Bessonnard  et al., 2014; 
Doughton et al., 2014; Ghimire et al., 2015). If the activation of FGF/MEK is inhibited 
in mouse embryos, the hypoblast formation can be suppressed, which indicates a 
blockage of development (Nicholas et al., 2009). Again, these facts were observed in 
bovine embryos (Modan et al., 2005). Notably, inhibition of FGF/MEK did not alter 
the segregation of epiblast and hypoblast in human embryos (Kuijk et al., 2012). 




In chapter 2, PCR result showed that STAT3 transcript was low in ICM from 
expanded blastocysts, while MEK and ERK transcripts were high. This suggested that 
cells are in a later stage of cat blastocyst development, and that the reliance switch 
from STAT3 to MEK/ERK may has already occurred. This finding also implied that 
could be other pathways involved, yet not identified. Even if the assessed cytokine 
combinations sustained partial pluripotent markers, results suggest that right timing of 
applying LIF and 2i to suppress development or maintain pluripotency may have been 
missed. A more thorough validation could be conducted with quantitative PCR for the 
transcripts and immunoassays (e.g. ICC, western blot) for receptor and pathway 
mediator proteins. In all, knowledge of what signaling controls cat early embryo 
development at different stages is critical. Approaches include, but are not limited to, 
RNA-sequence analysis, signaling pathway time-lapse tracking, and gene-engineering 
in cat embryos and cell lines obtained. These approaches are discussed in detail below 
with special consideration to the limited availability of cat embryos. 
RNA-sequence analysis, has been used to track the transcriptome change from 
ICM to ESCs in mouse (Tang et al., 2010). This research group has uncovered 
expression dynamics for over 2500 genes, with 6331 transcript variants in total. These 
indicated notable amount of alternative splicing. In the same study, a correlated change 
of epigenetic regulator and micro RNAs have been revealed in the same cell population, 
which allows the identification of genes that directly regulate transcription factor 
POU5F1. This analysis only required 20 single cells from the embryos to generated 
whole transcriptome (Tang et al., 2009). The sensitivity and reliability of the data are 
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encouraging for cat embryological studies, since the cat embryo production is more 
challenging compared to the mouse model, and assessment of embryo quality is still 
inadequate. The strategy for utilizing such technology could be single-cell comparison 
for transcriptome pattern change from 4-cell to expanded blastocyst, and single-cell 
comparisons for transcriptome difference regarding specification in morula and 
blastocysts. Once such dataset is established, there are several ways to improve the 
data interpretation, 1) comparing the data to what has been published in mouse and 
human studies (Yan et al., 2013), to locate genes upregulated and down-regulated 
specifically in cats, including long noncoding RNAs; 2) applying the time-expression 
clustering pattern (Tong et al., 2010) from mouse to cat dataset, to find the gene 
clusters that share the similar pattern during cell specification, especially the cluster 
resembling specific signaling pathways; 3) coupling with cell state surface markers to 
resolve heterogeneity in the embryos (Wilson et al., 2015); and 4) combining with 
chromatin immunoprecipitation sequence (Laurent et al., 2015), to reveal the 
modifiers on gene regulatory elements (Li et al., 2017). These analyses will help 
identify potential candidates for gene engineering, and comparatively define cell states 
in cat blastocysts (Rossant and Tam, 2009). It is noteworthy that there are technical 
errors that may be mistaken as extensive biological heterogeneity, especially when the 
biological variation is obvious in cat embryos produced in vitro, due to the 
uncontrolled parental resources. To confirm that a transcript is truly heterogeneous in 
a specific population of cat embryos, orthogonal validation using digital drop-let PCR 
and quantitative PCR would be essential (Wang et al., 2014), which requires additional 
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set of precious samples.  In addition to this challenge, the database of cat genome and 
its transcriptome is still in need of improvement, particularly for genetic studies in 
random bred cat embryos (Li et al., 2016; Montague et al., 2014).  
Time-lapse signaling pathway analysis by fluorescence anisotropy (Marchand et 
al., 2001) is another approach that would add to the RNA-sequence analysis in the cat 
model. For example, IL6 family has high evolutionary plasticity (Hsu et al., 2015), 
consisting of ciliary neurotrophic factor, cardiotrophin-like cytokine (CLC), CT1, IL6, 
IL11, LIF, IL-27 and oncostatin M (OSM), which can be labelled by fluorescent dyes. 
When bound, anisotropy could be detected. They are clustered into one family because 
the receptor of each cytokine contains two (IL-6 and IL-11) or one molecule (all other 
cytokines) of the signaling receptor and a subunit gp130 (Matsuo et al., 2014). After 
activation Janus kinase on the receptor, STAT3 will be phosphorylated. Thus, tracking 
the receptor fluctuation and IL6 family production in the embryos may lead to the 
discovery of the cytokines associated with cell specification in morula and blastocysts. 
The limitation in this approach is the selection of candidate signaling pathway is 
restricted to what has been validated in mouse and human, which may overlook the 
signaling pathways specific for cats. Fortunately, there is a novel protein analysis 
method that may compensate for this limitation, an integrated native mass 
spectrometry and top-down proteomics method (Li et al., 2018). It allows the 
macromolecules analyzed and structured in one single experiment, which minimizes 
the sample size, also the sensitivity is around 5 ppm which allows average protein 
concentrations as low as 10 pM. Using clustering analysis and ortholog identification, 
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the active signaling could be identified beyond the current understanding for cat 
embryos.  
After the identification of signaling pathways in cat embryos, the validation of 
signaling function could rely on gene-engineered embryos. To interfere with the 
normal embryo development before cell specification as little as possible, a condition 
knock out at morula stage could be used. The traditional Cre-flox system (Hoess et 
al.,1984) requires intensive selection of embryos bearing spontaneous homologous 
recombination, which cannot be fulfilled with limited amount of cat embryos 
specimens. A method using small interfering RNA has been generated recently 
(Ikeda et al., 2018). It includes a simple lipofection method to transfect siRNA into 
8-16-cell stage embryos using zona removal and the well-of-the-well culture system. 
This approach is more straightforward and can affect the embryos at desired time 
point. The reported knockdown efficiency was 35-88%, which may not be perfect. 
The limited number of cat embryos could restrict the use of such an approach, 
however with improved embryo production, this would be a valid evaluation of in-
dispensable pathways for development. The development and transcripts of 
interfered embryos will be assessed to determine if the gene is critical in regulating 
cell specification and differentiation in blastocysts. 
Once the signaling pathway are determined, formulation of cytokines that 
maintain pluripotency in cat embryos becomes much easier and more accurate.  
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4.2.2 Investigating cytokine effect with generated cell lines 
While the embryo experiment takes time to produce an answer, there can be 
alternative way to bulk screen known cytokines and small chemical molecules using 
cell lines. In chapter 3, the transduction efficiency was over 90%, yet the putative 
colony formation was low (0.002%). One of the major reasons could be that the 
cytokine combination used was not optimized for cat pluripotency maintenance. The 
transcript and protein analysis in the cells generated implied that the daughter colonies 
advanced to a direction towards differentiation. Based on the previous studies in mouse 
reprogramming (Zunder et al., 2015), there can be several sub-populations in the 
reprogrammed CFFs, NANOGlowPOU5F1lowpartial reprogrammed cells, fibroblast-
like cells, ESC-like NanoghighSox2high cells, and mesendoderm-like 
NanoglowSox2lowLin28high cells. The co-existence of such populations allows selection 
of two major groups of supplementations, cytokines that maintain pluripotency in 
ESC-like NanoghighSox2high cells, small chemicals that enhance pluripotency 
NANOGlowPOU5F1lowpartial reprogrammed cells, which together result in increased 
number of ESC-like colonies and stabilization of pluripotency in generated colonies.  
A successful chemical/cytokine reverse screening campaign must meet three 
requirements, 1) a group of robust markers, which allows to distinguish between potent 
and less potent molecules, 2) a quantitative assessment for candidate molecules to 
evaluate their efficiency, and (3) an experimental strategy for elucidating the 
connection of molecule and its target. In this study, the levels of NANOG, POU5F1 
were good markers representing pluripotent status. Cells can be engineered with two 
92 
 
reporter proteins, e.g. green fluorescence proteins and yellow fluorescence protein 
following NANOG, POU5F1 genes, respectively. The subpopulation may be sorted by 
the levels of co-expressions of the fluorescence proteins (Hayashi et al., 2011), and 
provide several populations with one or two fluorophores. The cells with high levels 
of both fluorophores are considered ESC-like cells and treated with different 
combinations of cytokines that are known effective in mouse and human ESC, 
including but not limited to LIF, IL6, OSM, CT1, GSK3 inhibitor, MEK inhibitor, ERK 
inhibitor, MAP2/3K inhibitors (Thorold et al., 2014). The endpoint evaluation would 
the homogeneity of colonies continuously expressing high levels of NANOG and 
POU5F1. The other population would be more of a mix of NANOGlowPOU5F1low, and 
NANOG/POUO5F1low, partial reprogrammed cells. This group can be used to select 
small chemicals that enhance pluripotency, and the endpoint assessment would be the 
efficiency of converting cells to NANOGhighPOU5F1high population. The pool of small 
chemicals is a combined library data set based on previous study in mouse (Hou et al., 
2013).   
During the process of optimizing reprogramming, a profiling of cell surface 
proteins (Collier et al., 2017) can be generated by comparing NANOGhighPOU5F1high 
to the other population. Surface proteins identified may be useful to track pluripotency 
dynamic in cat embryos. After all, the cytokine/small chemicals need to be validated 
on embryo-origin pluripotent stem cells. 
Back to the accomplishment in this dissertation, the generation of embryonic and 
reprogrammed cells has set a foundation of cell state markers, cytokine selection and 
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genome manipulation in the cat. The establishment of fast-proliferating cell lines have 
provided materials to optimize the condition for cat pluripotency regulation. With the 
proposed research above, a deeper understanding of pluripotency regulation in cat is 
anticipated, with the discovery of molecules that eventually provide the conditions that 
allow generation of ESCs and iPSCs for the feline family. 
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Appendix Table 1 Primers, target genes and anticipated products. 
RT-qPCR target              forward primer                      reverse primer               product (bp) 
cat KLF4 CTGACGAACTGACCAGGCAT TCTTCTTGGCAGTGTGGGTC 161 
 
POU5F1 GCCCGAAAGAGAAAGCGAAC AACCACACTCGGACCACATC 149 
 
NANOG CTCTCCTCTTCCTTCCT AGCTGGGTCTGAGAGAA 171 
 
SOX2 CTACAGCATGATGCAGGACCAG TGCTGCGAGTAGGACATGCT 180 
 
CMYC GCAGCGACTCTGAGGAAGAA AGGTTTGCTGTGGCCTCC 131 
 
REX1 AGGCATCTCCTCGTTCATGC AAACGTTTTCCGCACCCTTC 149 
 
FGF5 CGGATGGCAAAGTCAATGGC TCGGTAAATTTGGCACTTGCAT 160 
 
PAX6 TTCCCGAATTCTGCAGACCC GTCTGATGGAGCCAGTCTCG 119 
 
SOX1 CAAGATGCACAACTCGGAGATC TCCTTCTTGAGCAGCGTCTTGGTC 177 
 
Brachyury TGTCCAACGGGCTGGGAGCTC GTCCACGAGGCTATGAGGAGG 187 
 
FOXF1 TACTCGTACATCGCGCTCAT TGGTCCAGTAGTGGCCCTTG 220 
 
SOX17 CAGTGACGACCAGAGCCAGC GCGTTCATCGGCCGCCGGATGC 195 
 
GATA6 CCTGTGTGCAATGCTTGTGG GAGCAAGCTTTTGACTTATTTAT 128 
RT-PCR 
 
cat NANOG GAATACGGATCCAGCTCAGCC GTCTGGTTGCCCCATATTGGAA 600 
 
POU5F1 GGGGGATGACGTACTGTGG ATTGCAGAACCACACTCGGA 629 
 
SOX2 GAACCCCAAGATGCACAACTC CTGGAGTGGGAGGAAGAGGTAA 600 
 
KLF4 ACCTGCAGCTTCAGCTATCC GCTCTTGGTAATGGAGCGGT 685 
 
CMYC ACTCGGTGCAGCCCTATTTC TGCCACTGTCCAACTTAGCC 948 
 
LIF-R GGTACCATGCCCATCCATCTT TTCATTTCCCCCACCCACAT 756 
 
STAT3 GGTGTCAGATTACGTGGGCT TCAATGAATGGTGTCACACAGA 529 
 
FGF2-R AGCAGGAACATCGCATTGGA AGAAACCTGTCTCCGCAAGG 692 
 
MEK GTTTGGCGTATCTCCGGGAA GGCAGTCACTCCCGAATTGT 603 
 
ERK AGTGCACCTACTGCTTACCG CGTCATCCCAGGTGTTTCCA 284 
 
ACTIVIN-AR TGAGTGTCACATTGCCGGAG TGACTCAGCTACCTTAGGGCT  188 
 
BMP2-R CATTCCAAATCCAGCACCGC GGTAGCTGCTTTCTCTTGTGC 740 
 
SMAD4 TTAAACTCGGACCGGGACTC TGATGGCTGCCCTTCAAAGT  756 
 








CT CATAGCGTAAAAGGAGCAACAT 180 
 
SOX2-WPRE CCGGCACGGCCATTAACGGC CATAGCGTAAAAGGAGCAACAT 200 
 
KLF4-WPRE CGCTCAGATGAACTGACCAGG CATAGCGTAAAAGGAGCAACAT 150 
 
















Appendix Table 2 P values for relative fold change 
 


















NANOG 0.308 0.889 0.953 0.000 0.000 0.000 0.000 0.000 
POU5F1 0.118 0.122 0.006 0.728 0.999 0.276 0.007 0.000 
SOX2 0.002 0.005 0.007 0.999 0.728 0.822 0.000 0.001 
KLF4 1.000 0.994 0.348 0.998 1.000 0.429 0.623 0.000 
CMYC 0.047 0.007 0.014 0.819 0.510 0.353 0.010 0.000 
REX1 0.434 0.998 0.988 0.000 0.000 0.000 0.000 0.000 
FGF5 0.164 0.286 0.140 0.486 0.841 0.983 0.601 0.000 
Brachyury 0.000 0.002 0.004 N/A N/A N/A 0.000 N/A 
GATA6 0.319 1.000 0.998 0.000 0.000 0.000 0.000 0.000 
SOX17 0.000 0.000 0.000 0.298 0.091 0.080 0.000 0.050 
FOXF1 0.003 0.100 0.016 0.204 0.394 0.141 0.150 0.001 
PAX6 0.044 0.595 0.572 0.333 0.889 0.876 0.419 0.020 










Appendix Figure 1. Relative quantification of transcripts NANOG, POU5F1, SOX2, 
KLF4, CMYC, LIF-receptor, STAT3, FGF2-receptor, MEK, ERK, Activin A-receptor, 
BMP2-receptor and SMAD4.RPL17 was used as a reference gene. No significant 




Appendix Figure 2. Relative quantification of transcript in CFFs and iPSCs at different 
passages for transcripts NANOG, POU5F1, SOX2, KLF4, CMYC, REX1, FGF5, FGF2, 
Brachyury, GATA6, SOX17, FOXF1, PAX and SOX1.RPL17 was used as a reference 
gene, quantity = 2-






Appendix Figure 3. Embryoid body culture from iPSC at passage 10, A) Embryoid 
bodies were formed in hanging drops with 5000 cells; B) embryoid bodies were 




Appendix Figure 4. Cells stained without primary antibodies, but with all three 









Appendix Figure 5. Blastocysts were cultured without cytokine supplementations for 6 days. ICC was used 
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